Avon Products (AVP) 10-Q 14 Aug 20 2020 Q2 Quarterly report Financial data

Cover Page

Cover Page	6 Months Ended
	Jun. 30, 2020shares
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2020
Document Transition Report	false
Entity File Number	1-4881
Entity Registrant Name	AVON PRODUCTS, INC.
Entity Incorporation, State or Country Code	NY
Entity Tax Identification Number	13-0544597
Entity Address, Address Line One	Building 6, Chiswick Park
Entity Address, City or Town	London
Entity Address, Postal Zip Code	W4 5HR
Entity Address, Country	GB
Country Region	44
City Area Code	1904
Local Phone Number	232425
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	101.34
Entity Central Index Key	0000008868
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q2
Amendment Flag	false

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Revenue		$ 1,174.8		$ 2,361.7
Revenue from affiliates of Natura &Co	$ 1.8	0	$ 1.8	0
Total revenue	606.5	1,174.8	1,563.8	2,361.7
Costs, expenses and other:
Cost of sales	(250.5)	(497.5)	(671.5)	(1,014.5)
Selling, general and administrative expenses	(406.1)	(646.8)	(1,044.2)	(1,320.6)
Operating (loss) income	(50.1)	30.5	(151.9)	26.6
Interest expense	(31.7)	(30.7)	(63.5)	(63.9)
Loss on extinguishment of debt and credit facilities			(7.8)	(2)
Interest income	0.3	1.5	1.5	3.2
Other (expense) income, net	(0.9)	6.8	(19.1)	29.4
Gain on sale of business/assets	0.1	13.2	0.1	23.5
Total other expenses	(32.2)	(9.2)	(88.8)	(9.8)
(Loss) income from continuing operations, before income taxes	(82.3)	21.3	(240.7)	16.8
Income taxes	(6.1)	(27.2)	(14.9)	(46.7)
Loss from continuing operations, net of tax	(88.4)	(5.9)	(255.6)	(29.9)
Loss from discontinued operations, net of tax	(5.1)	(13.2)	(9.8)	(22.7)
Net loss	(93.5)	(19.1)	(265.4)	(52.6)
Net loss (income) attributable to noncontrolling interests	0.7	(0.4)	1.6	0.4
Net loss attributable to Avon	(92.8)	(19.5)	(263.8)	(52.2)
Product sales
Revenue	573.1	1,108.8	1,472.9	2,225
Total revenue	573.1		1,472.9
Other revenue
Revenue	$ 31.6	$ 66	$ 89.1	$ 136.7

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Statement of Comprehensive Income [Abstract]
Net loss	$ (93.5)	$ (19.1)	$ (265.4)	$ (52.6)
Other comprehensive (loss) income:
Foreign currency translation adjustments	(0.2)	4.1	(84)	1.2
Unrealized (loss) gain on revaluation of long-term intercompany balances	(3.3)	0.3	(26.6)	(0.2)
Change in unrealized gains, (losses) on cash flow hedges, net of taxes	0	(0.7)	0.6	(2.6)
Adjustments and amortization of net actuarial loss and prior service cost, net of taxes	2	1.8	4	3.1
Total other comprehensive (loss) income, net of income taxes	(1.5)	5.5	(106)	1.5
Comprehensive loss	(95)	(13.6)	(371.4)	(51.1)
Less: comprehensive loss (income) attributable to noncontrolling interests	0.7	(0.3)	1.8	0.4
Comprehensive loss attributable to Avon	$ (94.3)	$ (13.9)	$ (369.6)	$ (50.7)

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Statement of Comprehensive Income [Abstract]
Change in unrealized gain/losses on cash flow hedges, tax	$ 0	$ 0	$ 0	$ 0
Adjustments of and amortization of net actuarial loss and prior service cost, tax	$ (0.2)	$ (0.2)	$ 0.4	$ 0.3

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Current Assets
Cash and cash equivalents	$ 285.8	$ 650.6
Restricted cash	10.7	2.9
Accounts receivable, net	156.9	280.2
Receivables from affiliates of Natura &Co	1.9	0
Inventories	436.7	452.3
Prepaid expenses and other	240.5	252.1
Assets held for sale	12.3	22.6
Total current assets	1,144.8	1,660.7
Property, plant and equipment, at cost	1,086.6	1,203
Less accumulated depreciation	(665.7)	(715)
Property, plant and equipment, net	420.9	488
Right-of-use assets	160.1	175.4
Goodwill	76.9	86.2
Deferred tax asset	126.5	161.2
Other assets	438	514.8
Total assets	2,367.2	3,086.3
Current Liabilities
Debt maturing within one year	28.2	1.8
Loan from affiliates of Natura &Co	4.6	0
Accounts payable	538.8	723.3
Payables to affiliates of Natura &Co	91.5	0
Dividends payable	0	8.7
Accrued compensation	73.8	114.5
Other accrued liabilities	344.2	410.7
Sales taxes and taxes other than income	95.2	118.7
Income taxes	0	7.4
Current liabilities of discontinued operations	17.3	16
Total current liabilities	1,193.6	1,401.1
Long-term debt	1,593.1	1,590.4
Long-term operating lease liability	129.3	143.3
Employee benefit plans	130.5	137.6
Long-term income taxes	113.7	128.7
Other liabilities	86.5	90.5
Total liabilities	3,246.7	3,491.6
Series C convertible preferred stock	0	578.5
Shareholders’ Deficit
Common stock	0	192.6
Additional paid-in capital	524.2	2,321.2
Retained earnings	(262.9)	2,138.9
Accumulated other comprehensive loss	(1,145.8)	(1,040)
Treasury stock, at cost	0	(4,603.3)
Total Avon shareholders’ deficit	(884.5)	(990.6)
Noncontrolling interests	5	6.8
Total shareholders’ deficit	(879.5)	(983.8)
Total liabilities, series C convertible preferred stock and shareholders’ deficit	$ 2,367.2	$ 3,086.3

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions		3 Months Ended								6 Months Ended				12 Months Ended
		Jun. 30, 2020		Mar. 31, 2020		Jun. 30, 2019		Mar. 31, 2019		Jun. 30, 2020		Jun. 30, 2019		Dec. 31, 2019		Jun. 30, 2020		Dec. 31, 2019		Jun. 30, 2019
Cash Flows from Operating Activities
Net loss		$ (93.5)		$ (171.9)		$ (19.1)		$ (33.5)		$ (265.4)		$ (52.6)
Loss from discontinued operations, net of tax		(5.1)				(13.2)				(9.8)		(22.7)
Loss from continuing operations, net of tax		(88.4)				(5.9)				(255.6)		(29.9)
Adjustments to reconcile net loss from continuing operations to net cash used by operating activities:
Depreciation										30.2		36.5
Amortization										13.1		12.8
Provision for doubtful accounts										52.7		58.7
Provision for obsolescence										21.4		16.2
Share-based compensation										18.6		5.2
Foreign exchange losses (gains)										25.7		(7.3)
Deferred income taxes										14.9		7.3
Impairment loss on assets										0.7		13.3
Gain on sale of business / assets		(0.1)				(13.2)				(0.1)		(23.5)
Other										13.2		5.2
Changes in assets and liabilities:
Accounts receivable										36.8		(40.9)
Inventories										(52.6)		18
Prepaid expenses and other										(12)		15.2
Accounts payable and accrued liabilities										(191.7)		(211.3)
Income and other taxes										(23.7)		7.2
Noncurrent assets and liabilities										(15.8)		(18.3)
Net cash used by operating activities of continuing operations										(324.2)		(135.6)
Cash Flows from Investing Activities
Capital expenditures										(21.1)		(32.5)
Disposal of assets										1.1		0.8
Net proceeds from sale of business / assets										10		76.5
Other investing activities										0.4		0
Net cash (used) provided by investing activities of continuing operations										(9.6)		44.8
Cash Flows from Financing Activities
Cash dividends										(8.6)		0
Debt, net (maturities of three months or less)										10.1		0.5
Proceeds from debt										20		0
Repayment of debt										(0.2)		(0.3)
Repurchase of common stock										(0.4)		(1.1)
Settlement of stock options										(25.8)		0
Other financing activities										0		(9.2)
Net cash used by financing activities of continuing operations										(4.9)		(10.1)
Net cash used by operating activities of discontinued operations										(8.4)		(4.6)
Net cash used by discontinued operations										(8.4)		(4.6)
Effect of exchange rate changes on cash and cash equivalents, and restricted cash										(17.4)		(2.3)
Net decrease in cash and cash equivalents, and restricted cash										(364.5)		(107.8)
Cash and cash equivalents, and restricted cash at beginning of year	[1]			661				536.4		661		536.4		$ 536.4
Cash and cash equivalents, and restricted cash at end of period		296.5	[2]			428.6	[2]			296.5	[2]	428.6	[2]	661	[1]
Cash and cash equivalents, classified as held for sale																				$ 3.7
Cash and cash equivalents																$ 285.8		$ 650.6
Restricted cash																10.7		2.9
Long-term restricted cash	[3]															0		7.5
Cash and cash equivalents, and restricted cash at end of period per the statement of cash flows		$ 296.5	[2]	$ 661	[1]	$ 428.6	[2]	$ 536.4	[1]	$ 661	[1]	$ 428.6	[2]	$ 661	[1]	$ 296.5	[2]	$ 661	[1]	$ 428.6	[2]
[1]	The balance at the beginning of the six-month period ended June 30, 2019 includes cash and cash equivalents of $3.7 classified as Held for sale assets in our Consolidated Balance Sheets.
[2]	The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Consolidated Balance Sheet that sum to the total of the same such amounts shown in the Consolidated Statement of Cash Flows for the six-month period ended June 30, 2020. June 30, 2020 December 31, 2019 Cash and cash equivalents $ 285.8 $ 650.6 Restricted cash 10.7 2.9 Long-term restricted cash (1) — 7.5 Cash and cash equivalents, and restricted cash at end of period per the statement of cash flows $ 296.5 $ 661.0 (1) Long-term restricted cash is presented in other assets in our Consolidated Balance Sheets. The balance of $7.5 as of December 31, 2019 resulting from the sale of Avon Manufacturing (Guangzhou), Ltd has been reclassified to short-term restricted cash as of June 30, 2020.
[3]	Long-term restricted cash is presented in other assets in our Consolidated Balance Sheets. The balance of $7.5 as of December 31, 2019 resulting from the sale of Avon Manufacturing (Guangzhou), Ltd has been reclassified to short-term restricted cash as of June 30, 2020.

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholders' Deficit - USD ($) $ in Millions		Total	Cumulative effect adjustment	Common Stock		Additional Paid-in Capital		Retained Earnings		Retained EarningsCumulative effect adjustment	Accumulated Other Comprehensive Loss	Treasury Stock		Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2018				761,800,000								319,400,000
Beginning balance at Dec. 31, 2018		$ (896.8)		$ 190.3		$ 2,303.6		$ 2,234.3			$ (1,030.4)	$ (4,602.3)		$ 7.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income		(33.5)						(32.7)						(0.8)
Other comprehensive (loss) income		(3.9)									(4)			0.1
Dividends accrued - Series C convertible preferred stock		(6.2)						(6.2)
Exercise/ vesting/ expense of share-based compensation (in shares)				1,300,000
Exercise/ vesting/ expense of share-based compensation		(1.2)		$ 0.3		(1.5)
Purchases and sales of noncontrolling interests, net of dividends paid of $0.0		0.1												0.1
Ending balance (in shares) at Mar. 31, 2019				763,100,000								319,400,000
Ending balance at Mar. 31, 2019		(941.5)		$ 190.6		2,302.1		2,195.4			(1,034.4)	$ (4,602.3)		7.1
Beginning balance (in shares) at Dec. 31, 2018				761,800,000								319,400,000
Beginning balance at Dec. 31, 2018		(896.8)		$ 190.3		2,303.6		2,234.3			(1,030.4)	$ (4,602.3)		7.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income		(52.6)
Other comprehensive (loss) income		1.5
Ending balance (in shares) at Jun. 30, 2019				763,200,000								319,900,000
Ending balance at Jun. 30, 2019		(957.3)		$ 190.7		2,307.5		2,169.5			(1,028.9)	$ (4,603.3)		7.2
Beginning balance (in shares) at Mar. 31, 2019				763,100,000								319,400,000
Beginning balance at Mar. 31, 2019		(941.5)		$ 190.6		2,302.1		2,195.4			(1,034.4)	$ (4,602.3)		7.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income		(19.1)						(19.5)						0.4
Other comprehensive (loss) income		5.5									5.5
Dividends accrued - Series C convertible preferred stock		(6.4)						(6.4)
Exercise/ vesting/ expense of share-based compensation		5.4				5.4
Repurchase of common stock (in shares)				100,000								500,000
Repurchase of common stock		(1)		$ 0.1								$ (1)
Purchases and sales of noncontrolling interests, net of dividends paid of $0.0		(0.3)												(0.3)
Ending balance (in shares) at Jun. 30, 2019				763,200,000								319,900,000
Ending balance at Jun. 30, 2019		$ (957.3)		$ 190.7		2,307.5		2,169.5			(1,028.9)	$ (4,603.3)		7.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock (in dollars per share)		$ 0.25
Stock, shares authorized (in shares)		1,525,000,000
Common stock, authorized (in shares)		1,500,000,000
Preferred stock, authorized (in shares)		25,000,000
Preferred stock, par value (in dollars per share)		$ 1
Beginning balance (in shares) at Dec. 31, 2019				770,000,000								319,900,000
Beginning balance at Dec. 31, 2019		$ (983.8)	$ (2)	$ 192.6		2,321.2		2,138.9		$ (2)	(1,040)	$ (4,603.3)		6.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income		(171.9)						(171)						(0.9)
Other comprehensive (loss) income		(104.5)									(104.3)			(0.2)
Conversion of Series C convertible preferred stock (in shares)	[1]											(87,000,000)
Conversion of Series C convertible preferred stock	[1]	486.8						(710.8)				$ 1,197.6
Exercise/ vesting/ expense of share-based compensation		(9.9)		$ (0.2)		(9.7)
Exchange of common stock (in shares)	[2]			(770,000,000)								(232,900,000)
Exchange of common stock		0		$ (192.4)	[2]	(1,788.1)	[2]	(1,425.2)	[2]			$ 3,405.7	[2]
Ending balance (in shares) at Mar. 31, 2020	[3]			0								0
Ending balance at Mar. 31, 2020	[3]	(785.3)		$ 0		523.4		(170.1)			(1,144.3)	$ 0		5.7
Beginning balance (in shares) at Dec. 31, 2019				770,000,000								319,900,000
Beginning balance at Dec. 31, 2019		(983.8)	$ (2)	$ 192.6		2,321.2		2,138.9		$ (2)	(1,040)	$ (4,603.3)		6.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income		(265.4)
Other comprehensive (loss) income		(106)
Ending balance (in shares) at Jun. 30, 2020				0								0
Ending balance at Jun. 30, 2020		(879.5)		$ 0		524.2		(262.9)			(1,145.8)	$ 0		5
Beginning balance (in shares) at Mar. 31, 2020	[3]			0								0
Beginning balance at Mar. 31, 2020	[3]	(785.3)		$ 0		523.4		(170.1)			(1,144.3)	$ 0		5.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income		(93.5)												(0.7)
Other comprehensive (loss) income		(1.5)									(1.5)
Exercise/ vesting/ expense of share-based compensation		0.8				0.8
Ending balance (in shares) at Jun. 30, 2020				0								0
Ending balance at Jun. 30, 2020		$ (879.5)		$ 0		$ 524.2		$ (262.9)			$ (1,145.8)	$ 0		$ 5
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock (in dollars per share)		$ 0.01
Common stock shares outstanding (in shares)		101.34
[1]	On December 30, 2019, an affiliate of Cerberus Capital Management, L.P. ("Cerberus") elected to convert 435,000 shares of Series C Preferred Stock into 87,000,000 shares of the Company’s common stock, par value U.S.$0.25 per share, conditioned on the Conversion Condition (as defined below). See Note 13, Series C Convertible Preferred Stock.
[2]	In January 2020, subsequent to the Transaction, the Company restated its certificate of incorporation to effect a change in capitalization of the Company by changing the number of authorized shares of stock from 1,525,000,000 shares (of which (i) 1,500,000,000 shares, par value $0.25 per share, were common stock and (ii) 25,000,000 shares, par value $1.00 per share, were preferred stock) to 1,000 shares of common stock, par value $0.01 per share. As a result of the Merger, all of the issued and outstanding common stock of the Company, being 550,890,788, were canceled and converted. See Note 19, Mergers  with Natura Cosméticos S.A., to the Consolidated Financial Statements included herein.
[3]	The number of shares of Common Stock (par value $0.01 per share) outstanding at June 30, 2020 was 101.34.

Consolidated Statements of Ch_2

Consolidated Statements of Changes in Shareholders' Deficit (Parenthetical) - USD ($) $ in Millions	3 Months Ended
	Jun. 30, 2019	Mar. 31, 2019
Statement of Stockholders' Equity [Abstract]
Dividends	$ 0	$ 0

ACCOUNTING POLICIES

ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2020
Accounting Policies [Abstract]
ACCOUNTING POLICIES	ACCOUNTING POLICIES Basis of Presentation We prepare our unaudited interim Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States ("GAAP"). We consistently applied the accounting policies described in our 2019 Annual Report on Form 10-K ("2019 Form 10-K") in preparing these unaudited interim Consolidated Financial Statements, other than those impacted by new accounting standards as described below. In addition, upon the consummation of the Transaction with Natura &Co Holding S.A. ("Natura &Co Holding"), the Company became a wholly owned subsidiary of Natura &Co Holding and Avon common stock ceased to be traded on the NYSE. As a result, we have excluded disclosures of Earnings per Share from our consolidated financial statements. The Company has updated its reportable segments to align with how the business is operated and managed since the merger with Natura &Co Holding, we have identified two reportable segments based on geographic operations: Avon International and Avon Latin America. In prior periods, the Company reported four segments: Europe, Middle East and Africa, Asia Pacific, South Latin America and North Latin America. Previously reported segment information has been recast throughout the consolidated financial statements, as applicable, for all periods presented to reflect the changes in the Company’s reportable segments. Refer to Note 10, Segment Information, to the Consolidated Financial Statements contained herein for more information. In our opinion, the unaudited interim Consolidated Financial Statements reflect all adjustments of a normal recurring nature that are necessary for a fair statement of the results for the interim periods presented. Results for interim periods are not necessarily indicative of results for a full year. You should read these unaudited interim Consolidated Financial Statements in conjunction with our Consolidated Financial Statements contained in our 2019 Form 10-K. When used in this report, the terms "Avon," "Company," "we" or "us" mean Avon Products, Inc. For interim Consolidated Financial Statements purposes, we generally provide for accruals under our various employee benefit plans for each quarter based on one quarter of the estimated annual expense, and adjust these accruals as estimates are refined. In addition, our income tax provision is determined using an estimate of our consolidated annual effective tax rate, adjusted in the current period for discrete income tax items including: • the effects of significant, unusual or extraordinary pretax and income tax items, if any; • the impact of changes in tax legislation, if any; • withholding taxes recognized associated with cash repatriations; and • the impact of loss-making subsidiaries for which we cannot recognize an income tax benefit and subsidiaries for which an effective tax rate cannot be reliably estimated. Reclassifications Certain prior year amounts have been reclassified to conform to the current year presentation in the Consolidated Balance Sheets. As of June 30, 2020 and December 31, 2019, the Company had tooling, net of amortization of $8.4 and $12.9, respectively. The tooling balance as of December 31, 2019, representing cost of $94.4 and accumulated depreciation of $81.5, previously included in other long-term assets has been reclassified to property, plant and equipment to conform to the current year presentation. The prior period reflects the reclassification of the balance to conform to the current year presentation, which is consistent with industry practice. COVID-19 pandemic A novel strain of coronavirus (COVID-19) was first identified in Wuhan, China in December 2019, and subsequently declared a pandemic by the World Health Organization. During the second quarter of 2020, COVID-19 had a significant impact on our operations as many markets were subject to lockdown restriction s which limited our ability to recruit and enroll Representatives, operate manufacturing facilities and distribution centers and to process and deliver orders. Due to the uncertain and rapidly evolving nature of current conditions around the world, the impacts of COVID-19 most of which are beyond the Company’s control, continue to evolve, and the outcome is uncertain, we are therefore unable to predict accurately the impact that COVID-19 will have on our business going forward. We are closely monitoring the evolution of the COVID-19 pandemic and deciding on actions to minimize impacts, ensure the continuity of operations and promote the safety and health of all the people involved. Since the beginning of the virus spread and the consequent restrictive measures imposed by governments, such as closing non-essential trade and restricting the movement of people across borders, the Company has implemented some measures in all its operations, in line with the official measures: • Incentives to remote working and adoption of essentiality criteria to limit industrial and logistical operations; • Adoption of new safety measures for operational workers, such as the use of masks and procedures to distance people between processes; • Re-planning of sales cycles, prioritizing personal care items; • Speeding up the digitization of sales channels; • We communicated social distancing protocols to our Representatives around the world; • Change in the minimum order criteria, start kit and increased deadline for payment of Representatives; and • Daily monitoring of suppliers to ensure supply. As of the date of this report, we are unable to estimate the long term impact of the economic paralysis arising from efforts to curb the spread of the COVID-19 virus and the expected reduction in activity on our business, results of operations and financial condition. We will continue to review our revenue, investments, expenses and cash outflows, as well as adjusting our relationships with suppliers. Furthermore, the actions outlined above are continuously being re-evaluated in light of global developments relating to COVID-19. The impact of COVID-19 on our financial performance was more severe in the first half of the second quarter with signs of recovery in the second half of the quarter due to actions taken by the Company to operate during the pandemic and the easing of some lockdown restrictions. This recovery was subsequently impacted by the cyber incident later in the quarter. Cyber incident In June 2020, the Company became aware that it was exposed to a cyber incident in its Information Technology environment which interrupted some systems and partially affected operations. We engaged leading external cyber security and IT general controls specialists, launched a comprehensive containment and remediation effort and started a forensic investigation. As of the date of this report, the Company has re-established all of its core business processes and resumed operations in all of its markets, including all of its distribution centers. The Company continues to investigate and evaluate the extent of the cyber incident, while working diligently to mitigate its impacts and re-evaluate our IT general controls. The cyber incident had a significant impact on our revenue performance for the second quarter of 2020, with the majority of the impact (approximately $87 million in sales) being shifted to the third quarter of 2020 as the company fulfills the order backlog created. The incremental expense incurred as a result of the cyber incident in the second quarter of 2020 was not material. Although we have no indications that the accuracy and completeness of any financial information was impacted as a result of the incident and the Company has performed extensive procedures to validate such accuracy and completeness, we believe that, if the incident had gone differently, it could have potentially resulted in a material impact to the Company’s financial statements. Going concern We expect some negative impact on revenue from COVID-19 to continue for the remainder of 2020 which will, in turn, result in lower cash generation from activities. Our forecasts and projections indicate that we should have sufficient liquidity to meet our obligations for a period of not less than 12 months from the issuance date of the Consolidated Financial Statements contained herein. If the downturn is deeper or for longer than we anticipate, the Company could take certain further actions to ease the pressure of certain cash outflows, such as reducing discretionary expenditure, selling non-core assets, accessing government pandemic initiatives or arranging borrowing facilities with third-party banks and affiliate companies. Furthermore, the Company has received an irrevocable commitment from Natura &Co Holding management that they will provide sufficient financial support if and when needed to enable the Company to meet its obligations as they come due in the normal course of business for a period of not less than 12 months from the date issuance of the Consolidated Financial Statements contained herein. Accounting Standards Implemented ASU 2016-13, Financial Instruments - Credit Losses In June 2016, the FASB issued ASU 2016-13 estimation methods related to the allowance for doubtful accounts. The adoption resulted in a cumulative effect decrease to retained earnings of approximately $2 to reflect a change in the allowance for doubtful accounts. Accounting Standards to be Implemented ASU 2019-12, Simplifying the Accounting for Income Taxes In December 2019, the FASB issued ASU 2019-12, Income Taxes, which is intended to simplify the accounting standard and improve the usefulness of information provided in the financial statements. We intend to implement this new accounting guidance effective January 1, 2021, however early adoption is permitted. We are currently assessing the impact this new accounting guidance will have on our financial statements.

DISCONTINUED OPERATIONS, ASSETS

DISCONTINUED OPERATIONS, ASSETS AND LIABILITIES HELD FOR SALE AND DIVESTITURES	6 Months Ended
	Jun. 30, 2020
Discontinued Operations and Disposal Groups [Abstract]
DISCONTINUED OPERATIONS, ASSETS AND LIABILITIES HELD FOR SALE AND DIVESTITURES	DISCONTINUED OPERATIONS, ASSETS AND LIABILITIES HELD FOR SALE AND DIVESTITURES Discontinued Operations On December 17, 2015, the Company entered into definitive agreements with affiliates controlled by Cerberus. The agreements resulted in the separation of the Company’s North America business, which represented the Company’s operations in the United States, Canada and Puerto Rico, from the Company into New Avon Company, formerly New Avon, LLC ("New Avon"), a privately held company majority-owned and managed by Cerberus NA Investor LLC (an affiliate of Cerberus). The Company retained an investment of 19.9% ownership interest in New Avon. These transactions closed on March 1, 2016; from that date, resolution of contingent liabilities relating to Avon’s ownership and operation of the North America business prior to its separation from the Company into New Avon have been treated as discontinued operations. In April 2019, we signed an agreement with LG Household & Health Care Ltd. to sell our 19.9% ownership interest in New Avon, which was completed during August 2019. The Company incurred costs during the three and six months ended June 30, 2020 and 2019 following the resolution of certain contingent liabilities related to its ownership and operation of the North America business prior to its separation into New Avon. The major classes of financial statement components comprising the loss on discontinued operations, net of tax for New Avon are shown below: Three Months Ended June 30, Six Months Ended June 30, 2020 2019 2020 2019 Selling, general and administrative expenses $ 5.1 $ 13.2 $ 9.8 $ 22.7 Operating loss $ (5.1) $ (13.2) $ (9.8) $ (22.7) Loss from discontinued operations, net of tax $ (5.1) $ (13.2) $ (9.8) $ (22.7) Assets Held for Sale The major classes of assets comprising held for sale assets on the Consolidated Balance Sheets as of June 30, 2020 and December 31, 2019 are shown in the following table. June 30, 2020 December 31, 2019 Current held for sale assets Property, Plant and Equipment (net) 12.3 22.6 At December 31, 2019, in line with the Open Up Avon strategy the Company classified five properties which met the held for sale criteria under ASC 360 as "held for sale". During the first quarter of 2020, the Company decided not to proceed with the sale of one property in the Avon International segment and one property in the Avon Latin America segment with a carrying value of $9.1. As a result, the Company reclassified such properties from held for sale to property, plant and equipment during the first quarter of 2020. At the time of reclassification, we recorded a true up on depreciation resulting in an immaterial impact on our Consolidated Statements of Operations. During the second quarter of 2020, the Company decided to proceed with the sale of the one property in the Avon Latin America segment with a carrying value of $3.0. As a result, the Company reclassified the property from property, plant and equipment to held for sale and depreciation has ceased. At June 30, 2020, assets held for sale include two properties in Avon International segment and one property in the Avon Latin America Segment. Divestitures Hungary Distribution Center in Gödöllő In April 2020, we signed an agreement to sell the Hungary Distribution Center in Gödöllő for a selling price of $3.4, and received a deposit of $.3. In June 2020, we completed the sale of the asset and the remaining proceeds of $3.1 were received. These proceeds are presented as investing activities in the Consolidated Statement of Cash Flows. In the second quarter of 2020, we recorded a gain of $.1 before and after tax, which is reported separately in the Consolidated Statements of Operations. The gain represents the difference between the proceeds and the carrying value of the Hungary Distribution Center on the date of sale. China Wellness Plant In March 2020, we signed an agreement to sell the China Wellness Plant for a total selling price of $6.6 before expenses and we expect this transaction to close during the third quarter of 2020. In the six-month period ended June 30, 2020 we received a cash deposit for the selling price of $6.6, presented as investing activities in the Consolidated Statement of Cash Flows, which includes $3.3 of restricted cash. Rye Office On June 26, 2019, we completed the sale of the Rye office for a selling price of $23.2, less expenses of approximately $.8, resulting in proceeds of $22.4. These proceeds are presented as investing activities in the Consolidated Statement of Cash Flows. In the second quarter of 2019, we recorded a gain on sale of $9.9 before and after tax, which is reported separately in the Consolidated Statements of Operations. The gain recorded represents the difference between the proceeds and the carrying value of the Rye office on the date of sale. During the first quarter of 2019, we refined the calculation for the Held for sale assets which gave rise to an additional $.2 in assets. Malaysia Maximin On May 9, 2019, we completed the sale of all of the equity interests in Maximin Corporation Sdn Bhd ("Malaysia Maximin") for a total purchase price of $7.8. The cash proceeds of $7.6, net of expenses, are presented within investing activities in the Consolidated Statement of Cash Flows. In the second quarter of 2019, we recorded a gain on sale of $3.3 before tax, which is reported separately in the Consolidated Statements of Operations, and $3.0 after tax. The gain recorded represents the difference between the proceeds and the carrying value of Malaysia Maximin on the date of sale. During the second quarter of 2019, we refined the calculation for the Held for sale assets which gave rise to an additional $1.4 in assets. China manufacturing On February 15, 2019, we completed the sale to TheFaceShop Co., Ltd., an affiliate of LG Household & Health Care Ltd. ("TheFaceShop"), of all of the equity interests in Avon Manufacturing (Guangzhou), Ltd. for a total selling price of $71.0, less expenses of approximately $1.1. The selling price included $23.5 relating to outstanding intercompany loans payable to Avon Manufacturing (Guangzhou), Ltd. from other Avon subsidiaries that was presented as financing activities in the Consolidated Statement of Cash Flows, this was subsequently settled in April 2019. The cash proceeds of $46.4, net of loan amounts, are presented as investing activities in the Consolidated Statement of Cash Flows, which includes $7.5 of restricted cash as of December 31, 2019. This was subsequently reclassified to short-term restricted cash in the three-month period ended March 31, 2020.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Jun. 30, 2020
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONS On January 3, 2020, the Company became a wholly owned subsidiary of Natura &Co Holding. From this point Natura &Co Holding, its subsidiaries and affiliates became related parties of the Company. The following tables present the related party transactions with Natura &Co and its affiliates, New Avon, affiliates of Cerberus and the Instituto Avon in Braz il. There are no other related party transactions. On A ugust 14, 2019, we sold our investment in New Avon to LG Household & Health Care Ltd. Upon completion of the sale, New Avon was no longer a related party. Three Months Ended June 30, Six Months Ended June 30, 2020 2019 2020 2019 Statement of Operations Data Revenue from sale of product to New Avon (1) N/A $ 3.7 N/A $ 8.5 Gross profit from sale of product to New Avon (1) N/A $ — N/A $ .1 Cost of sales for purchases from New Avon (2) N/A $ .8 N/A $ 1.5 Revenue from affiliates of Natura &Co (8) $ 1.8 $ — $ 1.8 $ — Gross profit from affiliates of Natura &Co (8) $ .4 $ — $ .4 $ — Selling, general and administrative expenses related to New Avon: Transition services, intellectual property, technical support and innovation and subleases N/A $ (.1) N/A $ (.2) Project management team (3) N/A $ 2.1 N/A $ 3.4 Interest income from Instituto Avon (4) $ — $ .1 $ — $ .1 Interest expense on Loan from affiliates of Natura &Co (7) $ (.3) $ — $ (.3) $ — June 30, 2020 December 31, 2019 Balance Sheet Data Receivables due from Instituto Avon (4) $ 1.2 $ 2.1 Receivables due from affiliates of Natura &Co (8) $ 1.9 $ — Payables due to an affiliate of Cerberus (5) N/A $ 2.1 Payables due to affiliates of Natura &Co (6) $ 91.5 $ — Loan from affiliates of Natura &Co (7) $ 4.6 $ — (1) The Company supplies product to New Avon as part of a manufacturing and supply agreement. On August 14, 2019, the Company sold its investment in New Avon to LG Household & Health Care Ltd, from that point New Avon was no longer a related party. Transactions entered into with New Avon for the three and six month periods ended June 30, 2019 have been disclosed above. (2) New Avon supplies product to the Company as part of the same manufacturing and supply agreement discussed in footnote (1) above. The Company purchased $.6 from New Avon associated with this agreement during the three months ended June 30, 2019, and recorded $.8 associated with these purchases within cost of sales in our Consolidated Statement of Operations during the three months ended June 30, 2019. The Company purchased $1.4 from New Avon associated with this agreement during the six months ended June 30, 2019, and recorded $1.5 associated with these purchases within cost of sales in our Consolidated Statement of Operations during the six months ended June 30, 2019. Transactions entered into with New Avon for the three and six month periods ended June 30, 2019 have been disclosed above. On August 14, 2019, the Company sold its investment in New Avon to LG Household & Health Care Ltd; from that point New Avon was no longer a related party. (3) The Company also entered into agreements with an affiliate of Cerberus, which provided for the secondment of Cerberus affiliate personnel to the Company's project management team responsible for assisting with the execution of the implementation of the Company’s strategic initiatives. Furthermore, upon consummation of the Transaction with Natura &Co Holding in January 2020, Cerberus ceased being a related party. During the three and six months ended June 30, 2019 the Company recorded net costs of $2.1 and $3.4, respectively, in selling, general and administrative expenses associated with these agreements. (4) During the second quarter of 2018, the Company entered into an agreement to loan the Instituto Avon, an independent non-government charitable organization in Brazil, R$12 million (Brazilian reais) for an unsecured five-year term at a fixed interest rate of 7% per annum, to be paid back in five equal annual installments. The Instituto Avon was created by an Avon subsidiary in Brazil, with the board and executive team comprised of Avon Brazil management. The purpose of the loan was to provide the Instituto Avon with the means to donate funds to Fundação Pio XII (a leading cancer prevention and treatment organization in Brazil and owner of the Hospital do Câncer de Barretos), in order to invest in equipment with the objective of expanding breast cancer prevention and treatment. (5) Payables due to an affiliate of Cerberus related to the agreement for the project management team, classified within other accrued liabilities in our Consolidated Balance Sheets. Upon the consummation of Transaction with Natura in January 2020, Cerberus ceased their involvement in Company operations and is no longer a related party. (6) Upon consummation of the Transaction on January 3, 2020, the Company was acquired by Natura &Co Holding and became a wholly owned direct subsidiary of Natura &Co Holding. The payables due to Natura &Co Holding relate to the amount of accrued dividend paid by Natura &Co Holding in relation to Series C preferred stock and is presented separately in the Consolidated Balance Sheet. On December 30, 2019, Cerberus elected to convert 435,000 shares of series C preferred stock, representing all shares of series C preferred stock outstanding, into 87,000,000 shares of the Company’s common stock, par value U.S.$0.25 per share, pursuant to the holder of the Company’s series C preferred stock’s rights under the Company’s certificate of incorporation. The foregoing election was conditioned upon the filing of the certificates of merger with respect to the First Merger (the "Conversion Condition"). Upon consummation of the Transaction in January 2020, the Company’s common stock was converted to Natura &Co Holding common stock. In January 2020 Natura &Co Holding paid the accrued unpaid dividends on the shares of series C preferred stock in an amount equal to U.S. $91.5 to Cerberus. The Company intends to repay this balance. See Note 13, Series C Convertible Preferred Stock, for discussion of preferred shares issued to Cleveland Apple Investor L.P. ("Cerberus Investor") (an affiliate of Cerberus). (7) During the second quarter of 2020, the Company entered into an agreement to receive funding from Natura &Co Holding with respect to our Argentina operations. At June 30, 2020 the balance outstanding under this loan is 300 Argentinian Pesos, which is equivalent to $4.6. See Note 17, Debt for further details of the terms of this loan. (8) During the second quarter of 2020, the Company entered into manufacturing agreements with affiliates of Natura &Co Holding. The Company recorded revenue from related party of $1.8 and gross profit of $.4 associated with these agreements during the quarter ended June 30, 2020. The receivables from Natura &Co Holding relate to these manufacturing agreements.

REVENUE

REVENUE	6 Months Ended
	Jun. 30, 2020
Revenue from Contract with Customer [Abstract]
REVENUE	REVENUE Disaggregation of revenue In the following table, revenue is disaggregated by product or service type. All revenue is recognized at a point in time when control of a product is transferred to a customer: Three Months Ended June 30, 2020 Avon International Avon Latin America Total reportable segments Affiliates of Natura&Co Total Beauty: Skincare $ 122.6 $ 93.6 $ 216.2 $ — $ 216.2 Fragrance 78.7 70.8 $ 149.5 — 149.5 Color 45.3 29.9 $ 75.2 — 75.2 Total Beauty 246.6 194.3 440.9 — 440.9 Fashion & Home: Fashion 38.4 26.9 65.3 — 65.3 Home 7.8 59.1 66.9 — 66.9 Total Fashion & Home 46.2 86.0 132.2 — 132.2 Product sales 292.8 280.3 573.1 — 573.1 Representative fees 11.1 18.1 29.2 — 29.2 Other 1.1 1.3 2.4 1.8 4.2 Other revenue 12.2 19.4 31.6 1.8 33.4 Total revenue $ 305.0 $ 299.7 $ 604.7 $ 1.8 $ 606.5 Three Months Ended June 30, 2019 Avon International Avon Latin America Total Beauty: Skincare $ 165.9 $ 180.0 $ 345.9 Fragrance 143.0 160.1 303.1 Color 92.9 87.9 180.8 Total Beauty 401.8 428.0 829.8 Fashion & Home: Fashion 95.0 61.2 156.2 Home 13.8 109.0 122.8 Total Fashion & Home 108.8 170.2 279.0 Product sales 510.6 598.2 1,108.8 Representative fees 22.7 39.0 61.7 Other .8 3.5 4.3 Other revenue 23.5 42.5 66.0 Total revenue $ 534.1 $ 640.7 $ 1,174.8 Six Months Ended June 30, 2020 Avon International Avon Latin America Total reportable segments Affiliates of Natura&Co Total Beauty: Skincare $ 273.2 $ 239.6 $ 512.8 $ — $ 512.8 Fragrance 211.0 186.8 $ 397.8 — 397.8 Color 130.4 93.6 $ 224.0 — 224.0 Total Beauty 614.6 520.0 1,134.6 — 1,134.6 Fashion & Home: Fashion 111.2 70.2 $ 181.4 — 181.4 Home 20.9 136.0 $ 156.9 — 156.9 Total Fashion & Home 132.1 206.2 338.3 — 338.3 Product sales 746.7 726.2 1,472.9 — 1,472.9 Representative fees 31.3 48.8 $ 80.1 — 80.1 Other 4.1 4.9 $ 9.0 1.8 10.8 Other revenue 35.4 53.7 89.1 1.8 90.9 Total revenue $ 782.1 $ 779.9 $ 1,562.0 $ 1.8 $ 1,563.8 Six Months Ended June 30, 2019 Avon International Avon Latin America Total Beauty: Skincare $ 338.2 $ 357.0 $ 695.2 Fragrance 294.7 306.4 601.1 Color 200.0 170.0 370.0 Total Beauty 832.9 833.4 1,666.3 Fashion & Home: Fashion 198.4 122.1 320.5 Home 28.7 209.5 238.2 Total Fashion & Home 227.1 331.6 558.7 Product sales 1,060.0 1,165.0 2,225.0 Representative fees 47.0 78.6 125.6 Other 1.8 9.3 11.1 Other revenue 48.8 87.9 136.7 Total revenue $ 1,108.8 $ 1,252.9 $ 2,361.7 In January 2020 the Company became a fully owned subsidiary of Natura &Co Holding. As a result of this transaction, the Company has updated its reportable segments to align with how the business is operated and managed since the merger with Natura &Co Holding, we have identified two reportable segments based on geographic operations: Avon International and Avon Latin America. In prior periods, the Company reported four segments: Europe, Middle East and Africa, Asia Pacific, South Latin America and North Latin America. Previously reported segment information has been recast throughout the consolidated financial statements, as applicable, for all periods presented to reflect the changes in the Company’s reportable segments. Refer to Note 10, Segment Information, to the Consolidated Financial Statements contained herein for more information. Contract balances The timing of revenue recognition generally is different from the timing of a promise made to a Representative. As a result, we have contract liabilities, which primarily relate to the advance consideration received from Representatives prior to transfer of the related good or service for material rights, such as loyalty points and status programs, and are primarily classified within other accrued liabilities (with the long-term portion in other liabilities) in our Consolidated Balance Sheets. Generally, we record accounts receivable when we invoice a Representative. In addition, we record an estimate of an allowance for doubtful accounts on receivable balances based on an analysis of historical data and current circumstances, including seasonality, changing trends and the impact of COVID-19. The allowance for doubtful accounts is reviewed for adequacy, at a minimum, on a quarterly basis. We generally have no detailed information concerning, or any communication with, any ultimate consumer of our products beyond the Representative. We have no legal recourse against the ultimate consumer for the collection of any accounts receivable balances due from the Representative to us. If the financial condition of the Representatives were to deteriorate, resulting in their inability to make payments, additional allowances may be required. The following table provides information about receivables and contract liabilities from contracts with customers at June 30, 2020 and December 31, 2019: June 30, 2020 December 31, 2019 Accounts receivable, net of allowances of $57.0 and $66.6 $ 156.9 $ 280.2 Contract liabilities $ 39.1 $ 51.0 The contract liability balances relate to certain material rights (loyalty points, status program and prospective discounts). During the six months ended June 30, 2020, we recognized $34.5 of revenue related to the contract liability balance at the beginning of the six-month period ended June 30, 2020, as the result of performance obligations satisfied. In addition, we deferred an additional $25.9 related to certain material rights granted during the period, for which the performance obligations are not yet satisfied. Of the amount deferred during the period, substantially all will be recognized within a year, with the significant majority to be captured within a quarter. The remaining movement in the contract liability balance is attributable to foreign exchange differences arising on the translation of the balance as at June 30, 2020 as compared with December 31, 2019. Contract costs Incremental costs to obtain contracts, such as bonuses or commissions, are recognized as an asset if the entity expects to recover them. However, ASC 340-40, Other Assets and Deferred Costs , offers a practical expedient to recognize the incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that the entity otherwise would have recognized is one year or less. We elected the practical expedient and expense costs to obtain contracts when incurred because our amortization period is one year or less. Costs to fulfill contracts with Representatives are composed of shipping and handling (including order processing) and payment processing services, which are expensed as incurred. The fees for these services are included in the transaction price.

INVENTORIES

INVENTORIES	6 Months Ended
	Jun. 30, 2020
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES Components of Inventories June 30, 2020 December 31, 2019 Raw materials $ 128.8 $ 130.6 Finished goods 307.9 321.7 Total $ 436.7 $ 452.3

LEASES

LEASES	6 Months Ended
	Jun. 30, 2020
Leases [Abstract]
Leases	LEASES We have operating and finance leases for corporate and market offices, warehouses, automotive and other equipment. Some of our leases may include options to extend or terminate the lease. Certain leases also include options to purchase the leased property. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. Classification June 30, 2020 December 31, 2019 Assets Operating right-of-use assets Right-of-use asset $ 160.1 $ 175.4 Finance right-of-use assets Property, Plant and Equipment 1.9 2.4 Total right-of-use assets 162.0 177.8 Liabilities Current Operating lease liabilities Other accrued liabilities $ 44.3 $ 45.7 Finance lease liabilities Other accrued liabilities .6 1.0 Total current lease liabilities 44.9 46.7 Noncurrent Operating lease liabilities Long-term operating lease liability $ 129.3 $ 143.3 Finance lease liabilities Long-term debt 1.5 1.4 Total noncurrent lease liabilities $ 130.8 $ 144.7 Total lease liability $ 175.7 $ 191.4 The table below shows the lease income and expenses recorded in the Consolidated Statement of Operations incurred during the three and six months ended June 30, 2020 and 2019. Three months ended June 30, Six months ended June 30, Lease Costs Classification 2020 2019 2020 2019 Operating lease cost (1) Selling, general and administrative expenses $ 15.8 $ 16.6 $ 31.8 $ 33.3 Finance lease cost Amortization of right-of-use assets Selling, general and administrative expenses .3 .4 .6 .9 Interest on lease liabilities Interest Expense .1 .1 .1 .2 Short-term leases costs Selling, general and administrative expenses .6 .8 1.2 1.9 Sublease income (2) Selling, general and administrative expenses (4.5) (2.6) (8.6) (5.8) Net lease cost $ 12.3 $ 15.3 $ 25.1 $ 30.5 (1) Includes variable lease costs which are immaterial. These are presented in selling, general and administrative expenses in our Consolidated Statements of Operations. (2) Sublease portfolio consists of the sublease of our previous principal executive office located at 777 Third Avenue, New York, NY. The maturity analysis of the finance and operating lease liabilities is reflected below. This table also reflects the reconciliation of the undiscounted cash flows to the discounted finance and operating lease liabilities as recognized in the June 30, 2020 Consolidated Balance Sheet: Maturity of Lease Liabilities Operating Leases Finance Leases Total 2020 $ 32.4 $ .4 $ 32.8 2021 52.9 .9 53.8 2022 44.9 .7 45.6 2023 29.7 .2 29.9 2024 21.2 .1 21.3 2025 18.3 — 18.3 Thereafter 12.1 — 12.1 Total lease payments $ 211.5 $ 2.3 $ 213.8 Less: Interest (37.9) (.2) (38.1) Present value of lease liabilities $ 173.6 $ 2.1 $ 175.7 At December 31, 2019 our operating and finance lease obligations by due dates were as follows: Maturity of Lease Liabilities Operating Leases Finance Leases Total 2020 59.7 1.2 60.9 2021 50.5 .9 51.4 2022 42.4 .6 43.0 2023 28.3 .1 28.4 2024 20.2 — 20.2 Thereafter 30.1 — 30.1 Total lease payments $ 231.2 $ 2.8 $ 234.0 Less: Interest (42.2) (.4) (42.6) Present value of lease liabilities $ 189.0 $ 2.4 $ 191.4 The Company has calculated the weighted-average remaining lease term, presented in years below, and the weighted-average discount rate for our operating and finance lease population. The Company uses the incremental borrowing rate as the lease discount rate. Lease Term and Discount Rate June 30, 2020 December 31, 2019 Weighted-average remaining lease term (years) Operating leases 4.5 4.8 Finance leases 2.5 2.6 Weighted-average discount rate Operating leases 8.8 % 8.5 % Finance leases 12.5 % 11.2 % The table below sets out the classification of lease payments in the Consolidated Statement of Cash Flows. The right-of-use assets obtained in exchange for new finance and operating lease liabilities represent the new operating and finance leases entered into during the three and six months ended June 30, 2020. Three months ended June 30, Six months ended June 30, Other Information 2020 2019 2020 2019 Operating cash flows from operating leases $ 15.7 $ 15.8 $ 31.8 $ 32.1 Operating cash flows from finance leases .1 — .1 — Financing cash flows from finance leases .2 .3 .6 .7 Cash paid for amounts included in measurement of liabilities $ 16.0 $ 16.1 $ 32.5 $ 32.8 Right-of-use assets obtained in exchange for new finance liabilities $ .1 $ .1 $ .2 $ .9 Right-of-use assets obtained in exchange for new operating liabilities $ .8 $ 8.0 $ 12.8 $ 20.0
Leases	LEASES We have operating and finance leases for corporate and market offices, warehouses, automotive and other equipment. Some of our leases may include options to extend or terminate the lease. Certain leases also include options to purchase the leased property. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. Classification June 30, 2020 December 31, 2019 Assets Operating right-of-use assets Right-of-use asset $ 160.1 $ 175.4 Finance right-of-use assets Property, Plant and Equipment 1.9 2.4 Total right-of-use assets 162.0 177.8 Liabilities Current Operating lease liabilities Other accrued liabilities $ 44.3 $ 45.7 Finance lease liabilities Other accrued liabilities .6 1.0 Total current lease liabilities 44.9 46.7 Noncurrent Operating lease liabilities Long-term operating lease liability $ 129.3 $ 143.3 Finance lease liabilities Long-term debt 1.5 1.4 Total noncurrent lease liabilities $ 130.8 $ 144.7 Total lease liability $ 175.7 $ 191.4 The table below shows the lease income and expenses recorded in the Consolidated Statement of Operations incurred during the three and six months ended June 30, 2020 and 2019. Three months ended June 30, Six months ended June 30, Lease Costs Classification 2020 2019 2020 2019 Operating lease cost (1) Selling, general and administrative expenses $ 15.8 $ 16.6 $ 31.8 $ 33.3 Finance lease cost Amortization of right-of-use assets Selling, general and administrative expenses .3 .4 .6 .9 Interest on lease liabilities Interest Expense .1 .1 .1 .2 Short-term leases costs Selling, general and administrative expenses .6 .8 1.2 1.9 Sublease income (2) Selling, general and administrative expenses (4.5) (2.6) (8.6) (5.8) Net lease cost $ 12.3 $ 15.3 $ 25.1 $ 30.5 (1) Includes variable lease costs which are immaterial. These are presented in selling, general and administrative expenses in our Consolidated Statements of Operations. (2) Sublease portfolio consists of the sublease of our previous principal executive office located at 777 Third Avenue, New York, NY. The maturity analysis of the finance and operating lease liabilities is reflected below. This table also reflects the reconciliation of the undiscounted cash flows to the discounted finance and operating lease liabilities as recognized in the June 30, 2020 Consolidated Balance Sheet: Maturity of Lease Liabilities Operating Leases Finance Leases Total 2020 $ 32.4 $ .4 $ 32.8 2021 52.9 .9 53.8 2022 44.9 .7 45.6 2023 29.7 .2 29.9 2024 21.2 .1 21.3 2025 18.3 — 18.3 Thereafter 12.1 — 12.1 Total lease payments $ 211.5 $ 2.3 $ 213.8 Less: Interest (37.9) (.2) (38.1) Present value of lease liabilities $ 173.6 $ 2.1 $ 175.7 At December 31, 2019 our operating and finance lease obligations by due dates were as follows: Maturity of Lease Liabilities Operating Leases Finance Leases Total 2020 59.7 1.2 60.9 2021 50.5 .9 51.4 2022 42.4 .6 43.0 2023 28.3 .1 28.4 2024 20.2 — 20.2 Thereafter 30.1 — 30.1 Total lease payments $ 231.2 $ 2.8 $ 234.0 Less: Interest (42.2) (.4) (42.6) Present value of lease liabilities $ 189.0 $ 2.4 $ 191.4 The Company has calculated the weighted-average remaining lease term, presented in years below, and the weighted-average discount rate for our operating and finance lease population. The Company uses the incremental borrowing rate as the lease discount rate. Lease Term and Discount Rate June 30, 2020 December 31, 2019 Weighted-average remaining lease term (years) Operating leases 4.5 4.8 Finance leases 2.5 2.6 Weighted-average discount rate Operating leases 8.8 % 8.5 % Finance leases 12.5 % 11.2 % The table below sets out the classification of lease payments in the Consolidated Statement of Cash Flows. The right-of-use assets obtained in exchange for new finance and operating lease liabilities represent the new operating and finance leases entered into during the three and six months ended June 30, 2020. Three months ended June 30, Six months ended June 30, Other Information 2020 2019 2020 2019 Operating cash flows from operating leases $ 15.7 $ 15.8 $ 31.8 $ 32.1 Operating cash flows from finance leases .1 — .1 — Financing cash flows from finance leases .2 .3 .6 .7 Cash paid for amounts included in measurement of liabilities $ 16.0 $ 16.1 $ 32.5 $ 32.8 Right-of-use assets obtained in exchange for new finance liabilities $ .1 $ .1 $ .2 $ .9 Right-of-use assets obtained in exchange for new operating liabilities $ .8 $ 8.0 $ 12.8 $ 20.0

EMPLOYEE BENEFIT PLANS

EMPLOYEE BENEFIT PLANS	6 Months Ended
	Jun. 30, 2020
Retirement Benefits, Description [Abstract]
EMPLOYEE BENEFIT PLANS	EMPLOYEE BENEFIT PLANS Three Months Ended June 30, Pension Benefits Net Periodic Benefit Costs U.S. Plans Non-U.S. Plans Postretirement Benefits 2020 2019 2020 2019 2020 2019 Service cost (1) $ .4 $ .5 $ 1.0 $ 1.0 $ — $ — Interest cost .4 .6 2.8 3.8 .2 .3 Expected return on plan assets (.7) (.8) (3.8) (7.7) — — Amortization of prior service credit — — — — (.1) — Amortization of net actuarial losses .8 .7 1.5 1.3 — — Settlements/curtailments — — — — — — Net periodic benefit costs (1) $ .9 $ 1.0 $ 1.5 $ (1.6) $ .1 $ .3 Six Months Ended June 30, Pension Benefits Net Periodic Benefit Costs U.S. Plans Non-U.S. Plans Postretirement Benefits 2020 2019 2020 2019 2020 2019 Service cost (1) $ .8 $ 1.0 $ 2.1 $ 2.0 $ — $ — Interest cost .8 1.2 5.8 7.7 .3 .6 Expected return on plan assets (1.4) (1.6) (7.9) (15.6) — — Amortization of prior service credit — — — — — — Amortization of net actuarial losses 1.6 1.4 3.1 2.6 — — Settlements/curtailments — — — .1 — — Net periodic benefit costs (1) $ 1.8 $ 2.0 $ 3.1 $ (3.2) $ .3 $ .6 (1) Service cost is presented in selling, general and administrative expenses in our Consolidated Statements of Operations. The components of net periodic benefit costs other than service cost are presented in other income (expense), net in our Consolidated Statements of Operations. During the six months ended June 30, 2020, we made $2 of contributions to the U.S. and contributions of $3 to the non-U.S. defined benefit pension and postretirement benefit plans, respectively. During the remainder of 2020, we anticipate contributing approximately $0 to $5 to fund our global defined benefit pension and postretirement benefit plans.

CONTINGENCIES

CONTINGENCIES	6 Months Ended
	Jun. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
CONTINGENCIES	CONTINGENCIES Brazilian Tax Assessments In December 2012, our Brazilian subsidiary, Avon Industrial LTDA (Avon Brazil Manufacturing) received an excise tax ("IPI") assessment for the year 2008. The assessment totals approximately $179, including penalties and accrued interest. As in prior IPI cases that have been resolved in Avon’s favor, this assessment asserts that the establishment in 1995 of separate manufacturing and distribution companies in Brazil was done without a valid business purpose and that Avon Brazil Manufacturing did not observe minimum pricing rules to define the taxable basis of excise tax. The structure adopted in 1995 is comparable to that used by many other companies in Brazil. We believe that our Brazilian corporate structure is appropriate, both operationally and legally, and that the 2012 IPI assessment is unfounded. These matters are being vigorously contested. In July 2013, the 2012 IPI assessment was upheld at the first administrative level and we appealed this decision to the second administrative level. In April 2018, Avon received official notification that the second administrative level has issued a partially favorable and partially unfavorable decision. In this decision, the original assessment was reduced by approximately $47 (including associated penalty and interest). The remaining $179 of the assessment was upheld at the second administrative level. In April 2018, we appealed this decision in the third administrative level and in December 2019, we received an unfavorable decision in the third administrative level. In June 2020, Avon was formally notified of the December unfavorable decision and presented a Motion for Clarification. In the coming weeks we should receive a notice on whether that appeal will be accepted for trial. If the assessment is upheld by the third administrative level, the case will continue in the judicial sphere. In October 2017, Avon Brazil Manufacturing received a new tax assessment notice regarding IPI for the year 2014 on grounds similar to the 2012 assessment. The 2017 IPI assessment totals approximately $178, including penalties and accrued interest. In April 2018, Avon was notified of an unfavorable decision at the first administrative level. In February, 2019, this IPI assessment was upheld at the second administrative level and in April 2019 we appealed this decision to the third administrative level. In December 2019, the tax assessment was ruled unfavorable at the third Administrative level. Avon is waiting for the formal notification of this decision to further present a Motion of Clarification. After this motion is analyzed, if the assessment is upheld by the third administrative level, the case will continue in the judicial sphere. In the event that the 2012 and the 2017 IPI assessments are upheld in the third and final administrative level, it may be necessary to provide a guarantee letter or a deposit in the total amount of the debt to move the discussion in the judicial sphere. Depending on the circumstances, this may result in an adverse effect on the Company’s Consolidated Statements of Cash Flows. It is not possible to reasonably estimate the likelihood or potential amount of assessments that may be issued for subsequent periods (tax years through 2014 are closed by statute). We believe that the 2012 and the 2017 IPI assessments are unfounded. However, based on the likelihood that these will be upheld, we assess the risks as disclosed above as reasonably possible. As of June 30, 2020, we have not recognized a liability for the 2012 or 2017 IPI assessments. Brazil IPI Tax on Cosmetics In May 2015, an executive decree established the levy of IPI on the sales of cosmetic products by Avon Brazil. Avon Brazil filed an objection to this levy on the basis that it is not constitutional since this tax is already paid by Avon Brazil Manufacturing. In December 2016, Avon Brazil received a favorable decision from the Federal District Court regarding this objection. This decision has been appealed by the tax federal authority. From May 2015 through April 2016, Avon Brazil deposited in Court the amount relating to the IPI being discussed. In May 2016, Avon Brazil obtained an injunction authorizing the Company not to pay the IPI. As a result, in June 2018, Avon Brazil received a decision authorizing the Company to withdraw the amount deposited in Court and replace it with a letter of guarantee. In June 2018, the tax authorities presented an appeal against that decision. In July 2018, the amount deposited was withdrawn. In September 2018, due in part to contemporaneous judicial decisions in favor of taxpayers in the cosmetics industry and other developments, and supported by our legal counsel’s opinion, we assessed the IPI according to ASC 450, Contingencies and determined that the risk of loss was reasonably possible but not probable. Accordingly, we released the associated liability as of September 30, 2018 of approximately $195 and stopped accruing the IPI from October 1, 2018. The liability had been classified within long-term sales taxes and taxes other than income in our Consolidated Balance Sheet, and the release was recorded in product sales and other income (expense), net in the amounts of approximately $168 and approximately $27, respectively, in our Consolidated Income Statements for the quarter ended September 30, 2018. An unfavorable ruling to our objection of this IPI tax increase would have an adverse effect on the Company’s Consolidated Income Statements and Consolidated Statements of Cash Flows as Avon Brazil would have to remit the reasonably possible amount of $203 to the taxing authorities (including the judicial deposit that was returned to us on July 30, 2018). We are not able to reliably predict the timing of the outcome of our objection to this tax increase. A favorable judicial ruling to our objection of this IPI tax would also have an adverse effect on the Company’s Consolidated Statements of Cash Flows as Avon Brazil would have to remit all or a portion of the associated income tax liability to the taxing authorities. The Company is accruing a tax reserve, which amounts to approximately $68 at June 30, 2020. This reserve would be settled on final adjudication of the law through a combination of cash and use of deferred tax assets. Talc-Related Litigation The Company has been named a defendant in numerous personal injury lawsuits filed in U.S. courts, alleging that certain talc products the Company sold in the past were contaminated with asbestos. Many of these actions involve a number of co-defendants from a variety of different industries, including manufacturers of cosmetics and manufacturers of other products that, unlike the Company’s products, were designed to contain asbestos. As of June 30, 2020, there were 139 individual cases pending against the Company. During the three months ended June 30, 2020, 11 new cases were filed and three cases were dismissed, settled or otherwise resolved. The value of our settlements in this area thus far has not been material, either individually or in the aggregate. Additional similar cases arising out of the use of the Company’s talc products are reasonably anticipated. We believe that the claims asserted against us in these cases are without merit. We are defending vigorously against these claims and will continue to do so. To date, the Company has not proceeded to trial in any case filed against it and there have been no findings of liability enforceable against the Company. However, nationwide trial results in similar cases filed against other manufacturers of cosmetic talc products have ranged from outright dismissals to very large jury awards of both compensatory and punitive damages. Given the inherent uncertainties of litigation, we cannot predict the outcome of all individual cases pending against the Company, and we are only able to make a reasonable estimate for a small number of individual cases that have advanced to the later stages of legal proceedings. For the remaining cases, we provide an estimate of exposure on an aggregated and ongoing basis, which takes into account the historical outcomes of all cases we have resolved to date. Any accruals currently recorded on the Company’s balance sheet with respect to these cases are not material. Other than these accruals, we are at this time unable to estimate our reasonably possible or probable losses. However, any adverse outcomes, either in an individual case or in the aggregate, could be material. Future costs to litigate these cases, which we expense as incurred, are not known but may be significant, though some costs will be covered by insurance. Brazilian Labor-Related Litigation On an ongoing basis, the Company is subject to numerous and diverse labor-related lawsuits filed by employees in Brazil. These cases are assessed on an aggregated and ongoing basis based on historical outcomes of similar cases. The claims made are often for significantly larger sums than have historically been paid out by the Company. Our practice continues to be to recognize a liability based on our assessment of historical payments in similar cases. Our best estimate of the probable loss for such current cases at June 30, 2020 is approximately $4 and, accordingly, we have recognized a liability for this amount. Shareholder Litigation On February 14, 2019, a purported shareholder’s class action complaint (Bevinal v. Avon Products, Inc., et al., No. 19-cv-1420) was filed in the United States District Court for the Southern District of New York against the Company and certain former officers of the Company. On June 3, 2019, the court appointed a lead plaintiff and class counsel. The complaint was subsequently amended on June 28, 2019 and recaptioned "In re Avon Products, Inc. Securities Litigation" on July 8, 2019. On July 24, 2019, the plaintiffs filed a further amended complaint. The amended complaint is brought on behalf of a purported class consisting of all purchasers or acquirers of Avon common stock between January 21, 2016 and November 1, 2017, inclusive. The complaint asserts violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") based on allegedly false or misleading statements and alleged market manipulation with respect to, among other things, changes made to Avon’s credit terms for Representatives in Brazil. On July 26, 2019, Avon and the individual defendants filed a motion to dismiss. On November 18, 2019, the court denied that motion. Accordingly, on December 16, 2019, Avon and the individual defendants filed an answer to the amended complaint. On February 14, 2020, plaintiffs filed a motion for class certification. The parties have reached an agreement on a settlement of this class action. The terms of settlement include releases by members of the class of claims against the Company and the individual defendants and payment of $14.5 million. Approximately $2 million of the settlement will be paid by the Company (which represents the remaining deductible under the Company’s applicable insurance policies) and the remainder of the settlement will be paid by the Company’s insurers. Certain documentation relating to the settlement has not yet been finalized, and the settlement is subject to court approval. In the event the settlement is not approved by the court, or is otherwise terminated before it is finalized, the Company will be unable to predict the outcome of this matter. Furthermore, in that event, it is reasonably possible that the Company may incur a loss in connection with this matter, which the Company is unable to reasonably estimate. Other Matters Various other lawsuits and claims, arising in the ordinary course of business or related to businesses previously sold, are pending or threatened against Avon. In management’s opinion, based on its review of the information available at this time, the total cost of resolving such other contingencies at June 30, 2020, is not expected to have a material adverse effect on our consolidated financial position, results of operations or cash flows.

ACCUMULATED OTHER COMPREHENSIVE

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)	6 Months Ended
	Jun. 30, 2020
Equity [Abstract]
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)	ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) The tables below present the changes in AOCI by component and the reclassifications out of AOCI for the three and six months ended June 30, 2020 and 2019: Three Months Ended June 30, 2020 Foreign Currency Translation Adjustments Cash Flow Hedges Net Investment Hedges Pension and Postretirement Benefits Total Balance at March 31, 2020 $ (1,049.6) $ — $ (4.3) $ (90.4) $ (1,144.3) Other comprehensive loss other than reclassifications (3.5) — — — (3.5) Reclassifications into earnings: Amortization of net actuarial loss and prior service cost, net of tax of $0.2 (1) — — — 2.0 2.0 Total reclassifications into earnings — — — 2.0 2.0 Balance at June 30, 2020 $ (1,053.1) $ — $ (4.3) $ (88.4) $ (1,145.8) Three Months Ended June 30, 2019 Foreign Currency Translation Adjustments Cash Flow Hedges Net Investment Hedges Pension and Postretirement Benefits Investment in New Avon (2) Total Balance at March 31, 2019 $ (939.6) $ (1.4) $ (4.3) $ (92.5) $ 3.4 $ (1,034.4) Other comprehensive income (loss) other than reclassifications 4.4 (1.0) — — — 3.4 Reclassifications into earnings: Derivative loss on cash flow hedges, net of tax of $0.0 — .3 — — — .3 Amortization of net actuarial loss and prior service cost, net of tax of $0.2 1) — — — 1.8 — 1.8 Total reclassifications into earnings — .3 — 1.8 — 2.1 Balance as June 30, 2019 $ (935.2) $ (2.1) $ (4.3) $ (90.7) $ 3.4 $ (1,028.9) Six Months Ended June 30, 2020 Foreign Currency Translation Adjustments Cash Flow Hedges Net Investment Hedges Pension and Postretirement Benefits Total Balance at December 31, 2019 $ (942.7) $ (.6) $ (4.3) $ (92.4) $ (1,040.0) Other comprehensive loss other than reclassifications (110.4) — — — (110.4) Reclassifications into earnings: Derivative losses on cash flow hedges, net of tax of $0.0 — .6 — — .6 Amortization of net actuarial loss and prior service cost, net of tax of $0.4 (1) — — — 4.0 4.0 Total reclassifications into earnings — .6 — 4.0 4.6 Balance at June 30, 2020 $ (1,053.1) $ — $ (4.3) $ (88.4) $ (1,145.8) Six Months Ended June 30, 2019 Foreign Currency Translation Adjustments Cash Flow Hedges Net Investment Hedges Pension and Postretirement Benefits Investment in New Avon (2) Total Balance at December 31, 2018 $ (936.2) $ .5 $ (4.3) $ (93.8) $ 3.4 $ (1,030.4) Other comprehensive (loss) other than reclassifications 1.0 (3.4) — — — (2.4) Reclassifications into earnings: Derivative loss on cash flow hedges, net of tax of $0.0 — .8 — — — .8 Amortization of net actuarial loss and prior service cost, net of tax of $0.4 1) — — — 3.1 — 3.1 Total reclassifications into earnings — .8 — 3.1 — 3.9 Balance as June 30, 2019 $ (935.2) $ (2.1) $ (4.3) $ (90.7) $ 3.4 $ (1,028.9) For further details on Other Comprehensive loss other than reclassifications see the Consolidated Statement of Comprehensive Loss. (1) Gross amount reclassified to other income (expense), net in our Consolidated Statements of Operations, and related taxes reclassified to income taxes in our Consolidated Statements of Operations. (2) In April 2019, Avon and Cerberus signed an agreement with LG Household & Health Care Ltd. for the sale of New Avon, including our 19.9% ownership interest. In April 2019, Avon and Cerberus signed an agreement with LG Household & Health Care Ltd. for the sale of New Avon, including our 19.9% ownership interest. This transaction closed on August 14, 2019 and the related balance was reclassified into earnings. Foreign exchange net losses of $.1 and $2.3 for the three months ended June 30, 2020 and 2019, respectively, and foreign exchange net losses of $3.9 and $.7 for the six months ended June 30, 2020 and 2019, respectively,resulting from the translation of actuarial losses and prior service cost recorded in AOCI, are included in foreign currency translation adjustments in our Consolidated Statements of Comprehensive Loss.

SEGMENT INFORMATION

SEGMENT INFORMATION	6 Months Ended
	Jun. 30, 2020
Segment Reporting [Abstract]
SEGMENT INFORMATION	SEGMENT INFORMATION The Company has updated its reportable segments to align with how the business is operated and managed since the merger with Natura &Co Holding. We have identified two reportable segments based on geographic operations: Avon International and Avon Latin America. In prior periods, the Company reported four segments: Europe, Middle East and Africa, Asia Pacific, South Latin America and North Latin America. Previously reported segment information has been recast throughout the consolidated financial statements, as applicable, for all periods presented to reflect the changes in the Company’s reportable segments. We determine segment profit by deducting the related costs and expenses from segment revenue. Segment profit includes an allocation of central expenses to the extent the y support the operating activity of the segment. Segment profit excludes certain CTI restructuring initiatives, certain significant asset impairment charges, and other expenses, which are not allocated to a particular segment, if applicable. This is consistent with the manner in which we assess our performance and allocate resources. Summarized financial information concerning our reportable segments was as follows: Three Months Ended June 30, Six Months Ended June 30, Total Revenue 2020 2019 2020 2019 Avon International $ 305.0 $ 534.1 $ 782.1 $ 1,108.8 Avon Latin America 299.7 640.7 779.9 1,252.9 Total revenue from reportable segments (1) 604.7 1,174.8 1,562.0 2,361.7 Revenue from affiliates to Natura &Co 1.8 — 1.8 — Total revenue (1) 606.5 1,174.8 1,563.8 2,361.7 Three Months Ended June 30, Six Months Ended June 30, Operating Profit 2020 2019 2020 2019 Segment Profit Avon International $ (4.4) $ 44.5 $ (1.7) $ 94.5 Avon Latin America (50.8) 53.8 (68.0) 66.5 Total profit from reportable segments (2) $ (55.2) $ 98.3 $ (69.7) $ 161.0 Unallocated global expenses (3) (1.8) (9.0) (1.8) (18.0) Certain Brazil Indirect taxes (5) 10.6 — 10.6 — CTI restructuring initiatives (3.4) (45.7) (5.2) (99.2) Other expenses (4) (.3) (13.1) (85.8) (17.2) Operating profit $ (50.1) $ 30.5 $ (151.9) $ 26.6 (1) Total revenue also includes revenue from other operating segments and business activities of $2.4 and $4.5 for the three months ended June 30, 2020 and 2019 and $8.8 and $10.0 for the six months ended June 30, 2020 and 2019, respectively, allocated to Avon International and Avon Latin America segments. Other operating segments and business activities include revenue from the sale of products to New Avon since the separation of the Company’s North America business into New Avon on March 1, 2016 and ongoing royalties from the licensing of our name and products. Previously reported amount has been allocated to Avon International and Avon Latin America segments to conform to the current year presentation. (2) Total profit from reportable segments also includes profit from other operating segments and business activities and central expenses allocated to Avon International and Avon Latin America segments. Other operating segments and business activities of $1.2 and $.5 for the three months ended June 30, 2020 and 2019 and $4.1 and $1.1 for the six months ended June 30, 2020 and 2019, respectively, include profit from the sale of products to New Avon since the separation of the Company’s North America business into New Avon on March 1, 2016 and ongoing royalties from the licensing of our name and products. Central expenses of $39.3 and $65.3 for the three months ended June 30, 2020 and 2019 and $103.0 and $128.4 for the six months ended June 30, 2020 and 2019, respectively, include corporate general and administrative expenses allocated to Avon International and Avon Latin America to the extent they support the operating activity of the segment. Previously reported amounts has been allocated to segments to conform to the current year presentation. (3) For the three and six months ended June 30, 2020 unallocated global expenses include primarily stewardship and other expenses not directly attributable to reportable segments. (4) For the six months ended June 30, 2020, other expenses include primarily professional fees incurred in relation to the Transaction of approximately $44, severance payments of approximately $25 and acceleration of share based compensation of approximately $10 relating to these terminations triggered by change in control provisions. Refer to Note 19, Mergers with Natura Cosméticos S.A., to the Consolidated Financial Statements contained herein for more information relating to the Transaction. (5) The three and six-month periods ended June 30, 2020 include the impact of certain Brazil indirect taxes, which were recorded in selling, general and administrative expenses, net in the amounts of approximately $11 .

SUPPLEMENTAL BALANCE SHEET INFO

SUPPLEMENTAL BALANCE SHEET INFORMATION	6 Months Ended
	Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
SUPPLEMENTAL BALANCE SHEET INFORMATION	SUPPLEMENTAL BALANCE SHEET INFORMATION At June 30, 2020 and December 31, 2019, prepaid expenses and other included the following: Components of Prepaid Expenses and Other June 30, 2020 December 31, 2019 Prepaid taxes and tax refunds receivable $ 122.3 $ 141.1 Receivables other than trade (1) 70.9 51.4 Prepaid brochure costs, paper and other literature 11.2 13.1 Other 36.1 46.5 Prepaid expenses and other $ 240.5 $ 252.1 (1) As of June 30, 2020, the Company has recognized insurance receivables of $27 including $12 related to a contingent liability of approximately $15 for Shareholder Litigation, recognized in the Consolidated Balance Sheet under Other Accrued Liabilities. See Note 8, Contingencies. At June 30, 2020 and December 31, 2019, other assets included the following: Components of Other Assets (1) June 30, 2020 December 31, 2019 Net overfunded pension plans $ 96.0 $ 100.6 Capitalized software 71.6 83.1 Judicial deposits 48.5 70.1 Long-term receivables 161.8 196.1 Trust assets associated with supplemental benefit plans 35.8 37.3 Other 24.3 27.6 Other assets $ 438.0 $ 514.8 (1) As of June 30, 2020 and December 31, 2019, the Company had tooling, net of amortization of $8.4 and $12.9, respectively. Tooling balance as of December 31, 2019 previously included in other long-term assets has been reclassified to property, plant and equipment to conform to the current year presentation.

RESTRUCTURING INITIATIVES

RESTRUCTURING INITIATIVES	6 Months Ended
	Jun. 30, 2020
Restructuring and Related Activities [Abstract]
RESTRUCTURING INITIATIVES	RESTRUCTURING INITIATIVES Natura &Co - Avon Integration Subsequent to the merger of Natura and Avon in January 2020, an integration plan (the "Avon Integration") was established to create the right global infrastructure to support the future ambitions of the Natura &Co Group while also identifying synergies and opportunities to leverage our combined strength, scale and reach. Synergies will be derived mainly from procurement, manufacturing/distribution and administrative, including new top line synergies at Natura &Co Latin America, as well as cost synergies at Avon International. Open Up Avon, Open Up & Grow and Transformation Plan In January 2016, we initiated a transformation plan (the " Transformation Plan"), in order to enable us to achieve our long-term goals of mid-single-digit Constant $ revenue growth and low double-digit operating margin. There are no further restructuring actions to be taken associated with our Transformation Plan as, beginning in the third quarter of 2018, all new restructuring actions approved operate under our new Open Up Avon plan described below. In September 2018, we initiated a new strategy in order to return Avon to growth ( " Open Up Avon"). The Open Up Avon strategy is integral to our ability to return Avon to growth, built around the necessity of incorporating new approaches to various elements of our business, including increased utilization of third-party providers in manufacturing and technology, a more fit for purpose asset base, and a focus on enabling our Representatives to more easily interact with the company and achieve relevant earnings. These savings have been and are expected to continue to be achieved through restructuring actions (that have may continue to result in charges related to severance, contract terminations and inventory and other asset write-offs), as well as other cost-savings strategies that would not result in restructuring charges. In January 2019, we announced significant advancements in this strategy, including a structural reset of inventory processes and a reduction in global workforce. In May 2020, the new leadership of Avon refreshed our strategy ("Open Up & Grow") which aims to return Avon to growth over the next three years. Open Up & Grow replaces and builds on the success of the Open Up Avon strategy, launched in 2018 to strengthen competitiveness through enhancing the representative experience, improving brand position and relevance, accelerating digital expansion and improving costs. Over the next three years, savings are expected to continue to be achieved through restructuring actions (that may continue to result in charges related to severance, contract terminations and asset write-offs), as well as other cost-savings strategies that would not result in restructuring charges. Costs to Implement Restructuring Initiatives - Three and Six Months Ended June 30, 2020 and 2019 During the three months ended June 30, 2020, we recorded net costs to implement of $3.3, of which $1.5 related to Avon Integration, $2.0 related to Open Up & Grow and a benefit of $.2 related to the Transformation Plan, in our Consolidated Statements of Operations. During the three months ended June 30, 2019, we recorded costs to implement of $32.5 of which $28.3 related to Open Up Avon, a net benefit of $4.2 related to the Transformation Plan, in our Consolidated Statements of Operations. During the six months ended June 30, 2020, we recorded net costs to implement of $5.1, of which $1.5 related to Avon Integration, $6.9 related to Open Up & Grow and a benefit of $3.3 related to the Transformation Plan, in our Consolidated Statements of Operations. During the six months ended June 30, 2019, we recorded costs to implement of $75.7 of which $73.4 related to Open Up Avon, a net benefit of $2.2 related to the Transformation Plan, and $.1 related to other restructuring initiatives, in our Consolidated Statements of Operations. The costs during the three and six months ended June 30, 2020 and 2019 consisted of the following: Three Months Ended June 30, Six Months Ended June 30, 2020 2019 2020 2019 CTI recorded in operating profit - COGS Manufacturing asset write-offs $ — $ 6.0 $ — $ 9.8 Inventory write-off (.2) 2.6 (.3) 3.1 (.2) 8.6 (.3) 12.9 CTI recorded in operating profit - SG&A Net charges for employee-related costs, including severance benefits .6 13.4 (1.7) 48.6 Implementation costs, primarily related to professional service fees 1.2 17.3 .7 26.0 Dual running costs .7 2.6 1.5 4.5 Contract termination and other net benefits .7 1.4 3.0 4.6 Impairment of other assets — 2.3 .7 2.3 Accelerated depreciation — .1 .4 .3 Variable lease charges .4 — .9 — 3.6 37.1 5.5 86.3 CTI recorded in operating profit 3.4 45.7 5.2 99.2 CTI recorded in other (expense) income (Gain) loss on sale of business / assets (.1) (13.2) (.1) (23.5) Total CTI $ 3.3 $ 32.5 $ 5.1 $ 75.7 Avon Integration $ 1.5 $ — $ 1.5 Open Up & Grow $ 2.0 $ 28.3 $ 6.9 $ 73.4 Transformation Plan $ (.2) $ 4.2 $ (3.3) $ 2.2 Other $ — $ — $ — $ .1 The tables below include restructuring costs such as employee-related costs, inventory and asset write-offs, foreign currency translation write-offs and contract terminations, and do not include other costs to implement restructuring initiatives such as professional services fees, dual running costs, accelerated depreciation and gain on sale of business. The liability balance included in other accrued liabilities in our Consolidated Balance Sheet for the restructuring actions associated with Avon Integration at June 30, 2020 is $.7 related to employee related costs. The liability ba lance included in other accrued liabilities in our Consolidated Balance Sheet for the restructuring actions associated with Open Up & Grow at June 30, 2020 is as follows: Employee-Related Costs Inventory/Assets Write-offs Contract Terminations/Other Total Balance at December 31, 2019 $ 17.8 $ — $ 6.4 $ 24.2 2020 charges 1.2 .4 2.6 4.2 Adjustments (1.4) — .4 (1.0) Cash payments (7.8) — (6.6) (14.4) Non-cash write-offs — (.4) — (.4) Foreign exchange (.8) — — (.8) Balance at June 30, 2020 $ 9.0 $ — $ 2.8 $ 11.8 The liability balance included in other accrued liabilities in our Consolidated Balance Sheet for the restructuring actions associated with our Transformation Plan as of June 30, 2020 is as follows: Employee-Related Costs Contract Terminations/Other Total Balance at December 31, 2019 $ 8.4 $ 1.5 $ 9.9 2020 charges — — — Adjustments (2.9) — (2.9) Cash payments (1.9) (1.3) (3.2) Foreign exchange (.1) (.1) (.2) Balance at June 30, 2020 $ 3.5 $ .1 $ 3.6 The majority of cash payments, if applicable, associated with the year-end liability are expected to be made during 2020. The following table presents the restructuring charges incurred to date, under, Avon Integration, Open Up & Grow (formerly Open Up Avon) and the Transformation Plan, along with the estimated charges expected to be incurred on approved initiatives under the plans: Employee- Related Costs Inventory/ Asset Write-offs Contract Foreign Currency Translation Adjustment Write-offs Total Avon Integration Charges incurred to-date $ 1.5 $ — $ — $ — $ 1.5 Estimated charges to be incurred on approved initiatives — — — — — Total expected charges on approved initiatives $ 1.5 $ — $ — $ — $ 1.5 Open Up & Grow Charges incurred to-date $ 83.4 $ 107.9 $ 11.5 $ (10.9) $ 191.9 Estimated charges to be incurred on approved initiatives — — 2.5 $ — 2.5 Total expected charges on approved initiatives $ 83.4 $ 107.9 $ 14.0 $ (10.9) $ 194.4 Transformation Plan Charges incurred to-date $ 124.1 $ 2.5 $ 40.9 $ 3.4 $ 170.9 Estimated charges to be incurred on approved initiatives — — — — — Total expected charges on approved initiatives $ 124.1 $ 2.5 $ 40.9 $ 3.4 $ 170.9 The charges, net of adjustments, of initiatives under the Open Up Avon and the Transformation Plan, along with the estimated charges expected to be incurred on approved initiatives under the plans, by reportable segment are as follows: Avon International* Avon Latin America* Global & Other Operating Segments Total Avon Integration Second quarter 2020 .3 — 1.2 1.5 Charges incurred to-date .3 — 1.2 1.5 Estimated charges to be incurred on approved initiatives — — — — Total expected charges on approved initiatives $ .3 $ — $ 1.2 $ 1.5 Open Up & Grow 2018 $ 46.6 $ 64.3 $ 6.2 $ 117.1 2019 19.4 36.9 15.3 71.6 First quarter 2020 3.5 (.1) .2 3.6 Second quarter 2020 (1.0) (.1) .7 (.4) Charges incurred to-date 68.5 101.0 22.4 191.9 Estimated charges to be incurred on approved initiatives 2.5 — — 2.5 Total expected charges on approved initiatives $ 71.0 $ 101.0 $ 22.4 $ 194.4 Transformation Plan 2015 $ — $ — $ 21.4 $ 21.4 2016 40.0 17.6 16.8 74.4 2017 .4 5.0 49.4 54.8 2018 5.6 4.7 13.4 23.7 2019 (1.3) .6 .3 (.4) First quarter 2020 .1 .1 (3.0) (2.8) Second quarter 2020 (.2) — — (.2) Charges incurred to-date 44.6 28.0 98.3 170.9 Estimated charges to be incurred on approved initiatives — — — — Total expected charges on approved initiatives $ 44.6 $ 28.0 $ 98.3 $ 170.9 *In January 2020 the Company became a fully owned subsidiary of Natura &Co Holding. As a result of this transaction, the Company has updated its reportable segments to align with how the business is operated and managed since the merger with Natura &Co Holding. Previously reported segment information has been recast throughout the financial statements, as applicable, for all periods presented to reflect the changes in the Company’s reportable segments. Refer to Note 10, Segment Information, to the Consolidated Financial Statements contained herein for more information.

SERIES C CONVERTIBLE PREFERRED

SERIES C CONVERTIBLE PREFERRED STOCK	6 Months Ended
	Jun. 30, 2020
Equity [Abstract]
SERIES C CONVERTIBLE PREFERRED STOCK	SERIES C CONVERTIBLE PREFERRED STOCK On March 1, 2016, the Company issued and sold to Cerberus Investor 435,000 shares of newly issued series C preferred stock for an aggregate purchase price of $435 pursuant to an Investment Agreement, dated as of December 17, 2015, between the Company and Cerberus Investor. In connection with the issuance of the series C preferred stock, the Company incurred direct and incremental expenses of $8.7, composed of financial advisory fees and legal expenses, which reduced the carrying value of the series C preferred stock. Cumulative preferred dividends accrue daily on the series C preferred stock at a rate of 1.25% per quarter. The series C preferred stock had accrued unpaid dividends of $91.3 as of December 31, 2019. On December 19, 2019, the Company and Natura &Co Holding announced that as of such date, all regulatory approvals required by the Merger Agreement to complete the Transactions have been obtained. As a result, the series C preferred stock were probable of becoming redeemable and the redemption value was adjusted. Subsequently, on December 30, 2019, Cerberus elected to convert the series C preferred stock, and the series C preferred stock was no longer probable of becoming redeemable. We recognize changes in redemption value immediately as they occur and the carrying value of the security is adjusted to equal what the redemption amount would be as if redemption were to occur at the end of the reporting date based on the conditions that exist as of that date. As a result, we recognized an increase of $60.9 in the carrying value of the series C preferred stock for the year ended December 31, 2019. On December 30, 2019, Cerberus elected to convert 435,000 shares of series C preferred stock, representing all shares of series C preferred stock outstanding, into 87,000,000 shares of the Company’s common stock, par value U.S.$0.25 per share, pursuant to the holder of the Company’s series C preferred stock’s rights under the Company’s certificate of incorporation. The foregoing election was conditioned upon the filing of the certificates of merger with respect to the First Merger (the "Conversion Condition"). On January 3, 2020, the Company consummated the Transaction to become a wholly owned direct subsidiary of Natura &Co Holding. Upon consummation of the Transaction, the Company’s common stock was converted to Natura &Co Holding common stock. After the effective time of the Second Merger and in January 2020, Natura &Co Holding elected to pay the accrued dividends on the shares of series C preferred stock in an amount equal to $91.5 to Cerberus. See Note 19, Mergers with Natura Cosméticos S.A., and Note 3, Related Party Transactions.

GOODWILL

GOODWILL	6 Months Ended
	Jun. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL	GOODWILL Avon International Avon Latin America Total Net balance at December 31, 2019 * $ 20.0 $ 66.2 $ 86.2 Changes during the period ended June 30, 2020: Foreign exchange (1.0) (8.3) (9.3) Net balance at June 30, 2020 $ 19.0 $ 57.9 $ 76.9 *In January 2020 the Company became a fully owned subsidiary of Natura &Co Holding. As a result of this transaction, the Company has updated its reportable segments to align with Natura &Co Holding operations. Previously reported segment information has been recast throughout the financial statements, as applicable, for all periods presented to reflect the changes in the Company’s reportable segments. Refer to Note 10, Segment Information, to the Consolidated Financial Statements contained herein for more information.

FAIR VALUE

FAIR VALUE	6 Months Ended
	Jun. 30, 2020
Fair Value Disclosures [Abstract]
FAIR VALUE	FAIR VALUE Assets and Liabilities Recorded at Fair Value on a Recurring Basis The following table presents the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis as of June 30, 2020: Level 1 Level 2 Total Assets: Available-for-sale securities $ 4.2 $ — $ 4.2 Foreign exchange forward contracts $ — $ 2.7 $ 2.7 Total $ 4.2 $ 2.7 $ 6.9 Liabilities: Foreign exchange forward contracts $ — $ 10.1 $ 10.1 Total $ — $ 10.1 $ 10.1 The following table presents the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis as of December 31, 2019: Level 1 Level 2 Total Assets: Available-for-sale securities $ 4.3 $ — $ 4.3 Foreign exchange forward contracts $ — $ 5.6 $ 5.6 Total $ 4.3 $ 5.6 $ 9.9 Liabilities: Foreign exchange forward contracts $ — $ 3.8 $ 3.8 Total $ — $ 3.8 $ 3.8 Fair Value of Financial Instruments Our financial instruments include cash and cash equivalents, available-for-sale securities, short-term investments, accounts receivable, debt maturing within one year, accounts payable, long-term debt and foreign exchange forward contracts. The carrying value for cash and cash equivalents, accounts receivable, accounts payab le, debt maturing within one year and short-term investments approximate fair value because of the short-term nature of these instruments. The net asset (liability) amounts recorded in the balance sheet (carrying amount) and the estimated fair values of our remaining financial instruments at June 30, 2020 and December 31, 2019, respectively, consisted of the following: June 30, 2020 December 31, 2019 Carrying Fair Carrying Fair Available-for-sale securities $ 4.2 $ 4.2 $ 4.3 $ 4.3 Debt maturing within one year (28.2) (28.2) (1.8) (1.8) Long-term debt (1) (1,593.1) (1,634.3) (1,590.4) (1,748.1) Foreign exchange forward contracts (7.4) (7.4) 1.8 1.8 (1) The carrying value of long-term debt is presented net of debt issuance costs and includes any related discount or premium. The methods and assumptions used to estimate fair value are as follows: • Available-for-sale securities - The fair values of these investments were the quoted market prices for issues listed on securities exchanges. • Long-term debt - The fair values of our debt and other financing were determined using Level 2 inputs based on indicative market prices. • Foreign exchange forward contracts - The fair values of forward contracts were estimated based on quoted forward foreign exchange prices at the reporting date.

DERIVATIVE INSTRUMENTS AND HEDG

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	6 Months Ended
	Jun. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES We operate globally, with manufacturing and distribution facilities in various countries around the world. We may reduce our exposure to fluctuations in the fair value and cash flows associated with changes in interest rates and foreign exchange rates by creating offsetting positions, including through the use of derivative financial instruments. If we use foreign currency-rate sensitive and interest-rate sensitive instruments to hedge a certain portion of our existing and forecasted transactions, we would expect that any gain or loss in value of the hedge instruments generally would be offset by decreases or increases in the value of the underlying forecasted transactions. We do not enter into derivative financial instruments for trading or speculative purposes, nor are we a party to leveraged derivatives. The master agreements governing our derivative contracts generally contain standard provisions that could trigger early termination of the contracts in certain circumstances, including if we were to merge with another entity and the creditworthiness of the surviving entity were to be "materially weaker" than that of Avon prior to the Transaction. Derivatives are recognized in the Consolidated Balance Sheets at their fair values. The following table presents the fair value of derivative instruments at June 30, 2020: Asset Liability Balance Sheet Fair Balance Sheet Fair Derivatives not designated as hedges: Foreign exchange forward contracts Prepaid expenses and other $ 2.7 Accounts payable $ 10.1 Total derivatives $ 2.7 $ 10.1 Derivatives are recognized in the Consolidated Balance Sheets at their fair values. The following table presents the fair value of derivative instruments at December 31, 2019: Asset Liability Balance Sheet Fair Balance Sheet Fair Derivatives designated as hedges: Foreign exchange forward contracts Prepaid expenses and other $ — Accounts payable $ .6 Derivatives not designated as hedges: Foreign exchange forward contracts Prepaid expenses and other $ 5.6 Accounts payable $ 3.2 Total derivatives $ 5.6 $ 3.8 Interest Rate Risk At June 30, 2020 and December 31, 2019, our exposure to floating interest rate risk was minimal as over 98% of our borrowings are at fixed rates of interest. Only our short-term debt, which represents approximately 2% of our debt portfolio, is exposed to floating interest rates. Foreign Currency Risk We may use foreign exchange forward contracts to manage a portion of our foreign currency exchange rate exposures. At June 30, 2020, we had outstanding foreign exchange forward contracts with notional amounts totaling approximately $917 for various currencies, none of which were designated as cash flow hedges. We may use foreign exchange forward contracts to manage foreign currency exposure of certain intercompany loans. The change in fair value of these contracts is immediately recognized in earnings and substantially offsets the foreign currency translation impact recognized in earnings relating to the associated intercompany loans. During the three months ended June 30, 2020 and 2019, we recorded losses of $3.7 and $3.1, respectively, in other (expense) income, net in our Consolidated Statements of Operations related to these undesignated foreign exchange forward contracts. During the six months ended June 30, 2020 and 2019, we recorded gains of $6.8 and $21.9, respectively, in other (expense) income, net in our Consolidated Statements of Operations related to these undesignated foreign exchange forward contracts.

DEBT

DEBT	6 Months Ended
	Jun. 30, 2020
Debt Disclosure [Abstract]
DEBT	DEBT Short-term financing During the second quarter of 2020, the Company’s subsidiary, Cosmeticos Avon S.A.C.I entered into an agreement to receive funding from Natura Cosmeticos S.A., a subsidiary of Natura &Co Holding S.A and an affiliate of the Company in the amount of 300 million Argentine Peso which may be used for working capital and other general corporate purposes (t he "Argentina Facility"). Any borrowings under the Argentina Facility will bear interest at a rate per annum of 29.81% and has a six-month maturity. At June 30, 2020 the balance outstanding under this loan is $4.6. In addition, during the second quarter of 2020, we utilized approximately $28 of short-term financing from third-party banks across multiple markets. Natura Revolving Credit Facility In May 2020, the Company’s subsidiary, Avon Luxembourg Holdings S.à r.l entered into a Revolving Credit Facility Agreement with Natura &Co International S.à r.l,. a subsidiary of Natura &Co Holding S.A. and an affiliate of the Company in the amount of $100 which may be used for working capital and other general corporate purposes (the "Facility"). Any borrowings under the Facility will bear interest at a rate per annum of LIBOR plus 7.7% and the Facility will mature on May 31, 2022. As at June 30, 20 20, $0 was outstanding under the Facility. On July 3, 2020, $40 was borrowed under the Facility for a six-month tenor. 2019 Revolving Credit Facility In February 2019, Avon International Capital, p.l.c. ("AIC"), a wholly owned foreign subsidiary of the Company, entered into a three-year €200.0 senior secured revolving credit facility (the "2019 facility") and capitalized $11.0 of issuance costs, the related cash outflow is presented in other financing activities within the 10-K Consolidated Statement of Cash Flows. The 2019 facility was available for general corporate and working capital purposes. As of December 31, 2019, there were no amounts outstanding under the 2019 facility and on January 3, 2020, the facility was automatically canceled upon change of control, and as a result $7.8 of unamortized issuance costs were written off, see Note 19, Mergers with Natura Cosméticos S.A., to the Consolidated Financial Statements included herein. Unsecured Notes In March 2013, we issued a series of unsecured notes (the "2013 Notes"). As of June 30, 2020, the following 2013 Notes remain outstanding; $461.9 aggregate principal amount of 5% Notes due March 15, 2023 and $243.8 aggregate principal amount of 6.95% Notes due March 15, 2043. Interest on the 2013 Notes is payable semiannually on March 15 and September 15 of each year. The indenture governing the 2013 Notes contains interest rate adjustment provisions depending on the long-term credit ratings assigned to the 2013 Notes by S&P and Moody’s. The interest rate on the 2013 Notes is currently at the maximum allowable level of 2% above the respective interest rates in effect on date of issuance. Senior Secured Notes In August 2016, Avon International Operations, Inc. ("AIO"), issued $500.0 in aggregate principal amount of 7.875% Senior Secured Notes due August 15, 2022 (the "2016 Notes"). Interest on the 2016 Notes is payable semi-annually on February 15 and August 15 of each year. In July 2019, AIC issued $400.0 in aggregate principal amount of 6.5% Senior Secured Notes due August 15, 2022 (the "2019 Notes"). Interest on the 2019 Notes is payable semi-annually on February 15 and August 15 of each year. For a more detailed description of the Company’s debt agreements, refer to Note 8, Debt and Other Financing of our Annual Report on Form 10-K for the year ended December 31, 2019.

INCOME TAXES

INCOME TAXES	6 Months Ended
	Jun. 30, 2020
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES Our quarterly income tax provision is calculated using an estimated annual effective income tax approach. The quarterly effective tax rate can differ from our estimated annual effective tax rate as the Company cannot apply an effective tax rate approach for all of its operations. For those entities that can apply an effective tax rate approach, as of June 30, 2020, our annual effective tax rate, excluding discrete items, is 27.5% for 2020, as compared to 26.0% as of June 30, 2019. The remaining entities, which are operations that generate pre-tax losses which cannot be tax benefited and/or have an effective tax rate which cannot be reliably estimated, have to account for their income taxes on a discrete year-to-date basis as of the end of each quarter and are excluded from the effective tax rate approach. The estimated annual effective tax rate for 2020 also excludes the unfavorable impact of withholding taxes associated with certain intercompany payments, including royalties, service charges, interest and dividends, which in the aggregate are relatively consistent each year due to the need to repatriate funds to cover U.S. and U.K. based costs, such as interest on debt and central expenses. Withholding taxes associated with the relatively consistent intercompany payments are accounted for discretely and accrued in the provision for income taxes as they become due. The provision for income taxes for the three months ended June 30, 2020 and 2019 was $6.1 and $27.2, respectively. Our effective tax rates for the three months ended June 30, 2020 and 2019 were (7.4)% and 127.7%, respectively. The provision for income taxes for the six months ended June 30, 2020 and 2019 were $14.9 and $46.7, respectively. Our effective tax rates for the six months ended June 30, 2020 and 2019 were (6.2)% and 278.0%. The effective tax rates for the three months ended June 30, 2020 and 2019 were impacted by CTI restructuring charges which could not all be benefitted, country mix of earnings and withholding taxes. The effective tax rate in the second quarter of 2020 was unfavorably impacted by miscellaneous income tax expense of approximately $2.3. The effective tax rate for the second quarter of 2019 was also negatively impacted by the accrual of miscellaneous income tax expenses of approximately $.6. The effective tax rates for the six months ended June 30, 2020 and 2019 were impacted by CTI restructuring charges which could not all be benefitted, country mix of earnings and withholding taxes. The effective tax rate in the first half of 2020 was also unfavorably impacted by miscellaneous income tax expense of approximately $3.8. The effective tax rate in the first half of 2019 was also favorably impacted by the accrual of net income tax benefits of approximately $2.9 associated with the release of income tax reserves of approximately $3.3 associated with our uncertain tax positions net of other miscellaneous income tax expenses of approximately $.4 . In prior years, we had previously recorded valuation allowances against certain deferred tax assets associated with the U.S. and various foreign jurisdictions. We intend to continue maintaining these valuation allowances on our deferred tax assets until there is sufficient evidence to support the reversal of all or some portion of these allowances. Release of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease to income tax expense for the period the release is recorded. However, the exact timing and amount of the valuation allowance release are subject to change on the basis of the level of profitability that we are able to actually achieve.

MERGER WITH NATURA COSMETICOS S

MERGER WITH NATURA COSMETICOS S.A.	6 Months Ended
	Jun. 30, 2020
Business Combinations [Abstract]
MERGER WITH NATURA COSMETICOS S.A.	MERGER WITH NATURA COSMÉTICOS S.A. On May 22, 2019, the Company entered into the Agreement and Plan of Mergers (as amended by Amendment Number One to Agreement and Plant of Mergers, dated as of October 3, 2019, and as further amended by Amendment Number Two to Agreement and Plan of Mergers, dated as of November 5, 2019, the "Merger Agreement") among the Company, Natura Cosméticos S.A., a Brazilian corporation (sociedade anônima) ("Natura Cosméticos"), Natura &Co Holding S.A., a Brazilian corporation (sociedade anônima), Nectarine Merger Sub I, Inc., a Delaware corporation and a direct wholly owned subsidiary of Natura &Co Holding ("Merger Sub I"), and Nectarine Merger Sub II, Inc., a Delaware corporation and a direct wholly owned subsidiary of Merger Sub I ("Merger Sub II"), pursuant to which (i) Natura &Co Holding, after the completion of certain restructuring steps, holds all issued and outstanding shares of Natura Cosméticos, (ii) Merger Sub II merged with and into the Company, with the Company surviving the merger (the "First Merger") and (iii) Merger Sub I merged with and into Natura &Co Holding (the "Second Merger"), with Natura &Co Holding surviving the merger and as a result of which the Company and Natura Cosméticos became wholly owned direct subsidiaries of Natura &Co Holding (collectively, the "Transaction"). The Transaction was consummated on January 3, 2020, and at this time, the Company became a wholly owned direct subsidiary of Natura &Co Holding. In connection with the Transaction, trading of the Company’s stock was suspended by the NYSE, and the Company’s common stock was subsequently delisted and deregistered. On completion of the Transaction, each share of t he Company’s common stock issued and outstanding immediately prior to the consummation of the Transaction was converted into the ultimate right to receive, (i) 0.300 validly issued and allotted, fully paid-up American Depositary Shares of Natura &Co Holding, ("Natura &Co Holding ADSs") against the deposit of two shares of common stock of Natura &Co Holding ("Natura &Co Holding Shares", subject to adjustment in accordance with the terms of the Merger Agreement, and any cash in lieu of fractional Natura &Co Holding ADSs or (ii) 0.600 validly issued and allotted, fully paid-up Natura &Co Holding Shares, subject to adjustment in accordance with the terms of the Merger Agreement, and any cash in lieu of fractional Natura &Co Holding Shares. The Company’s Series C Preferred Stock held by Cerberus Investor were converted to common stock prior to consummation of the Transaction and were therefore automatically converted into common stock of Natura &Co; see Note 13, Series C Convertible Preferred Stock. Natura &Co Holding Shares are listed on the B3 S.A. - Brasil, Bolsa, Balcão stock exchange, and Natura &Co Holding ADSs are listed on the NYSE. Additionally, upon the consummation of the Transaction, Avon common stock ceased to be traded on the NYSE. In January 2020, subsequent to the Transaction, the Company restated the certificate of incorporation. The certificate of incorporation was restated to effect a change in capitalization of the Company by changing the number of authorized shares of stock from 1,525,000,000 shares (of which (i) 1,500,000,000 shares, par value $0.25 per share, are common stock and (ii) 25,000,000 shares, par value $1.00 per share, are preferred stock) to 1,000 shares of common stock, par value $0.01 per share. As a result, all of the issued and outstanding common stock of the Company, being 550,890,788 were canceled and converted into 101.34 common stock, par value $0.01 per share, and all outstanding treasury shares were canceled. The Company incurred costs of $45 and $44 in relation to the Transaction, primarily professional fees during the six months ended June 30, 2020 and the year ended December 31, 2019, respectively. During January 2020, it was announced that the employment of certain senior officers of the Company would be terminated, in connection with the Transaction. The Company incurred severance of approximately $24 and acceleration of share based compensation of approximately $10 relating to these terminations triggered by change in control provisions. As a result of the Transaction, the Company made payments of approximately $26 related to the settlement of stock options. In addition, any remaining restricted stock units and performance restricted stock units were exchanged for awards of Natura &Co Holding. The replacement awards contain substantially the same terms and conditions of the original awards except for the removal of the performance conditions. As such, the replacement awards contain only a service vesting condition. On consummation of the Transaction, a deferred compensation scheme relating to former employees of the Company became payable which resulted in extinguishing the liability and a cash outflow of approximately $12. In January 2020, upon completion of the Transaction, the Company’s revolving credit facility was canceled, triggered by change in control provisions. As a result, debt issuance costs of $7.8 were written off. As a result of the Transaction, the Company will no longer have access to certain tax attributes of approximately $480 to approximately $550 in certain taxing jurisdictions.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS On July 3, 2020, the Company borrowed $40 under the $100 Revolving Credit Facility with a subsidiary of Natura &Co Holding S.A. for a six-month tenor.

ACCOUNTING POLICIES (Policy)

ACCOUNTING POLICIES (Policy)	6 Months Ended
	Jun. 30, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation We prepare our unaudited interim Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States ("GAAP"). We consistently applied the accounting policies described in our 2019 Annual Report on Form 10-K ("2019 Form 10-K") in preparing these unaudited interim Consolidated Financial Statements, other than those impacted by new accounting standards as described below. In addition, upon the consummation of the Transaction with Natura &Co Holding S.A. ("Natura &Co Holding"), the Company became a wholly owned subsidiary of Natura &Co Holding and Avon common stock ceased to be traded on the NYSE. As a result, we have excluded disclosures of Earnings per Share from our consolidated financial statements. The Company has updated its reportable segments to align with how the business is operated and managed since the merger with Natura &Co Holding, we have identified two reportable segments based on geographic operations: Avon International and Avon Latin America. In prior periods, the Company reported four segments: Europe, Middle East and Africa, Asia Pacific, South Latin America and North Latin America. Previously reported segment information has been recast throughout the consolidated financial statements, as applicable, for all periods presented to reflect the changes in the Company’s reportable segments. Refer to Note 10, Segment Information, to the Consolidated Financial Statements contained herein for more information. In our opinion, the unaudited interim Consolidated Financial Statements reflect all adjustments of a normal recurring nature that are necessary for a fair statement of the results for the interim periods presented. Results for interim periods are not necessarily indicative of results for a full year. You should read these unaudited interim Consolidated Financial Statements in conjunction with our Consolidated Financial Statements contained in our 2019 Form 10-K. When used in this report, the terms "Avon," "Company," "we" or "us" mean Avon Products, Inc. For interim Consolidated Financial Statements purposes, we generally provide for accruals under our various employee benefit plans for each quarter based on one quarter of the estimated annual expense, and adjust these accruals as estimates are refined. In addition, our income tax provision is determined using an estimate of our consolidated annual effective tax rate, adjusted in the current period for discrete income tax items including: • the effects of significant, unusual or extraordinary pretax and income tax items, if any; • the impact of changes in tax legislation, if any; • withholding taxes recognized associated with cash repatriations; and
Reclassifications	ReclassificationsCertain prior year amounts have been reclassified to conform to the current year presentation in the Consolidated Balance Sheets.
Accounting Standards Implemented	Accounting Standards Implemented ASU 2016-13, Financial Instruments - Credit Losses In June 2016, the FASB issued ASU 2016-13 estimation methods related to the allowance for doubtful accounts. The adoption resulted in a cumulative effect decrease to retained earnings of approximately $2 to reflect a change in the allowance for doubtful accounts. Accounting Standards to be Implemented ASU 2019-12, Simplifying the Accounting for Income Taxes In December 2019, the FASB issued ASU 2019-12, Income Taxes, which is intended to simplify the accounting standard and improve the usefulness of information provided in the financial statements. We intend to implement this new accounting guidance effective January 1, 2021, however early adoption is permitted. We are currently assessing the impact this new accounting guidance will have on our financial statements.

DISCONTINUED OPERATIONS, ASSE_2

DISCONTINUED OPERATIONS, ASSETS AND LIABILITIES HELD FOR SALE AND DIVESTITURES (Tables)	6 Months Ended
	Jun. 30, 2020
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Discontinued Operations	The major classes of financial statement components comprising the loss on discontinued operations, net of tax for New Avon are shown below: Three Months Ended June 30, Six Months Ended June 30, 2020 2019 2020 2019 Selling, general and administrative expenses $ 5.1 $ 13.2 $ 9.8 $ 22.7 Operating loss $ (5.1) $ (13.2) $ (9.8) $ (22.7) Loss from discontinued operations, net of tax $ (5.1) $ (13.2) $ (9.8) $ (22.7)
Major Classes of Financial Statement Components Comprising the Loss on Discontinued Operations	The major classes of assets comprising held for sale assets on the Consolidated Balance Sheets as of June 30, 2020 and December 31, 2019 are shown in the following table. June 30, 2020 December 31, 2019 Current held for sale assets Property, Plant and Equipment (net) 12.3 22.6

RELATED PARTY TRANSACTIONS (Tab

RELATED PARTY TRANSACTIONS (Tables)	6 Months Ended
	Jun. 30, 2020
Related Party Transactions [Abstract]
Schedule of Related Party Transactions	The following tables present the related party transactions with Natura &Co and its affiliates, New Avon, affiliates of Cerberus and the Instituto Avon in Braz il. There are no other related party transactions. On A ugust 14, 2019, we sold our investment in New Avon to LG Household & Health Care Ltd. Upon completion of the sale, New Avon was no longer a related party. Three Months Ended June 30, Six Months Ended June 30, 2020 2019 2020 2019 Statement of Operations Data Revenue from sale of product to New Avon (1) N/A $ 3.7 N/A $ 8.5 Gross profit from sale of product to New Avon (1) N/A $ — N/A $ .1 Cost of sales for purchases from New Avon (2) N/A $ .8 N/A $ 1.5 Revenue from affiliates of Natura &Co (8) $ 1.8 $ — $ 1.8 $ — Gross profit from affiliates of Natura &Co (8) $ .4 $ — $ .4 $ — Selling, general and administrative expenses related to New Avon: Transition services, intellectual property, technical support and innovation and subleases N/A $ (.1) N/A $ (.2) Project management team (3) N/A $ 2.1 N/A $ 3.4 Interest income from Instituto Avon (4) $ — $ .1 $ — $ .1 Interest expense on Loan from affiliates of Natura &Co (7) $ (.3) $ — $ (.3) $ — June 30, 2020 December 31, 2019 Balance Sheet Data Receivables due from Instituto Avon (4) $ 1.2 $ 2.1 Receivables due from affiliates of Natura &Co (8) $ 1.9 $ — Payables due to an affiliate of Cerberus (5) N/A $ 2.1 Payables due to affiliates of Natura &Co (6) $ 91.5 $ — Loan from affiliates of Natura &Co (7) $ 4.6 $ — (1) The Company supplies product to New Avon as part of a manufacturing and supply agreement. On August 14, 2019, the Company sold its investment in New Avon to LG Household & Health Care Ltd, from that point New Avon was no longer a related party. Transactions entered into with New Avon for the three and six month periods ended June 30, 2019 have been disclosed above. (2) New Avon supplies product to the Company as part of the same manufacturing and supply agreement discussed in footnote (1) above. The Company purchased $.6 from New Avon associated with this agreement during the three months ended June 30, 2019, and recorded $.8 associated with these purchases within cost of sales in our Consolidated Statement of Operations during the three months ended June 30, 2019. The Company purchased $1.4 from New Avon associated with this agreement during the six months ended June 30, 2019, and recorded $1.5 associated with these purchases within cost of sales in our Consolidated Statement of Operations during the six months ended June 30, 2019. Transactions entered into with New Avon for the three and six month periods ended June 30, 2019 have been disclosed above. On August 14, 2019, the Company sold its investment in New Avon to LG Household & Health Care Ltd; from that point New Avon was no longer a related party. (3) The Company also entered into agreements with an affiliate of Cerberus, which provided for the secondment of Cerberus affiliate personnel to the Company's project management team responsible for assisting with the execution of the implementation of the Company’s strategic initiatives. Furthermore, upon consummation of the Transaction with Natura &Co Holding in January 2020, Cerberus ceased being a related party. During the three and six months ended June 30, 2019 the Company recorded net costs of $2.1 and $3.4, respectively, in selling, general and administrative expenses associated with these agreements. (4) During the second quarter of 2018, the Company entered into an agreement to loan the Instituto Avon, an independent non-government charitable organization in Brazil, R$12 million (Brazilian reais) for an unsecured five-year term at a fixed interest rate of 7% per annum, to be paid back in five equal annual installments. The Instituto Avon was created by an Avon subsidiary in Brazil, with the board and executive team comprised of Avon Brazil management. The purpose of the loan was to provide the Instituto Avon with the means to donate funds to Fundação Pio XII (a leading cancer prevention and treatment organization in Brazil and owner of the Hospital do Câncer de Barretos), in order to invest in equipment with the objective of expanding breast cancer prevention and treatment. (5) Payables due to an affiliate of Cerberus related to the agreement for the project management team, classified within other accrued liabilities in our Consolidated Balance Sheets. Upon the consummation of Transaction with Natura in January 2020, Cerberus ceased their involvement in Company operations and is no longer a related party. (6) Upon consummation of the Transaction on January 3, 2020, the Company was acquired by Natura &Co Holding and became a wholly owned direct subsidiary of Natura &Co Holding. The payables due to Natura &Co Holding relate to the amount of accrued dividend paid by Natura &Co Holding in relation to Series C preferred stock and is presented separately in the Consolidated Balance Sheet. On December 30, 2019, Cerberus elected to convert 435,000 shares of series C preferred stock, representing all shares of series C preferred stock outstanding, into 87,000,000 shares of the Company’s common stock, par value U.S.$0.25 per share, pursuant to the holder of the Company’s series C preferred stock’s rights under the Company’s certificate of incorporation. The foregoing election was conditioned upon the filing of the certificates of merger with respect to the First Merger (the "Conversion Condition"). Upon consummation of the Transaction in January 2020, the Company’s common stock was converted to Natura &Co Holding common stock. In January 2020 Natura &Co Holding paid the accrued unpaid dividends on the shares of series C preferred stock in an amount equal to U.S. $91.5 to Cerberus. The Company intends to repay this balance. See Note 13, Series C Convertible Preferred Stock, for discussion of preferred shares issued to Cleveland Apple Investor L.P. ("Cerberus Investor") (an affiliate of Cerberus). (7) During the second quarter of 2020, the Company entered into an agreement to receive funding from Natura &Co Holding with respect to our Argentina operations. At June 30, 2020 the balance outstanding under this loan is 300 Argentinian Pesos, which is equivalent to $4.6. See Note 17, Debt for further details of the terms of this loan. (8) During the second quarter of 2020, the Company entered into manufacturing agreements with affiliates of Natura &Co Holding. The Company recorded revenue from related party of $1.8 and gross profit of $.4 associated with these agreements during the quarter ended June 30, 2020. The receivables from Natura &Co Holding relate to these manufacturing agreements.

REVENUE (Tables)

REVENUE (Tables)	6 Months Ended
	Jun. 30, 2020
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	All revenue is recognized at a point in time when control of a product is transferred to a customer: Three Months Ended June 30, 2020 Avon International Avon Latin America Total reportable segments Affiliates of Natura&Co Total Beauty: Skincare $ 122.6 $ 93.6 $ 216.2 $ — $ 216.2 Fragrance 78.7 70.8 $ 149.5 — 149.5 Color 45.3 29.9 $ 75.2 — 75.2 Total Beauty 246.6 194.3 440.9 — 440.9 Fashion & Home: Fashion 38.4 26.9 65.3 — 65.3 Home 7.8 59.1 66.9 — 66.9 Total Fashion & Home 46.2 86.0 132.2 — 132.2 Product sales 292.8 280.3 573.1 — 573.1 Representative fees 11.1 18.1 29.2 — 29.2 Other 1.1 1.3 2.4 1.8 4.2 Other revenue 12.2 19.4 31.6 1.8 33.4 Total revenue $ 305.0 $ 299.7 $ 604.7 $ 1.8 $ 606.5 Three Months Ended June 30, 2019 Avon International Avon Latin America Total Beauty: Skincare $ 165.9 $ 180.0 $ 345.9 Fragrance 143.0 160.1 303.1 Color 92.9 87.9 180.8 Total Beauty 401.8 428.0 829.8 Fashion & Home: Fashion 95.0 61.2 156.2 Home 13.8 109.0 122.8 Total Fashion & Home 108.8 170.2 279.0 Product sales 510.6 598.2 1,108.8 Representative fees 22.7 39.0 61.7 Other .8 3.5 4.3 Other revenue 23.5 42.5 66.0 Total revenue $ 534.1 $ 640.7 $ 1,174.8 Six Months Ended June 30, 2020 Avon International Avon Latin America Total reportable segments Affiliates of Natura&Co Total Beauty: Skincare $ 273.2 $ 239.6 $ 512.8 $ — $ 512.8 Fragrance 211.0 186.8 $ 397.8 — 397.8 Color 130.4 93.6 $ 224.0 — 224.0 Total Beauty 614.6 520.0 1,134.6 — 1,134.6 Fashion & Home: Fashion 111.2 70.2 $ 181.4 — 181.4 Home 20.9 136.0 $ 156.9 — 156.9 Total Fashion & Home 132.1 206.2 338.3 — 338.3 Product sales 746.7 726.2 1,472.9 — 1,472.9 Representative fees 31.3 48.8 $ 80.1 — 80.1 Other 4.1 4.9 $ 9.0 1.8 10.8 Other revenue 35.4 53.7 89.1 1.8 90.9 Total revenue $ 782.1 $ 779.9 $ 1,562.0 $ 1.8 $ 1,563.8 Six Months Ended June 30, 2019 Avon International Avon Latin America Total Beauty: Skincare $ 338.2 $ 357.0 $ 695.2 Fragrance 294.7 306.4 601.1 Color 200.0 170.0 370.0 Total Beauty 832.9 833.4 1,666.3 Fashion & Home: Fashion 198.4 122.1 320.5 Home 28.7 209.5 238.2 Total Fashion & Home 227.1 331.6 558.7 Product sales 1,060.0 1,165.0 2,225.0 Representative fees 47.0 78.6 125.6 Other 1.8 9.3 11.1 Other revenue 48.8 87.9 136.7 Total revenue $ 1,108.8 $ 1,252.9 $ 2,361.7
Receivables and Contract Liabilities from Contracts with Customers	The following table provides information about receivables and contract liabilities from contracts with customers at June 30, 2020 and December 31, 2019: June 30, 2020 December 31, 2019 Accounts receivable, net of allowances of $57.0 and $66.6 $ 156.9 $ 280.2 Contract liabilities $ 39.1 $ 51.0

INVENTORIES (Tables)

INVENTORIES (Tables)	6 Months Ended
	Jun. 30, 2020
Inventory Disclosure [Abstract]
Schedule of Components of Inventories	Components of Inventories June 30, 2020 December 31, 2019 Raw materials $ 128.8 $ 130.6 Finished goods 307.9 321.7 Total $ 436.7 $ 452.3

LEASES (Tables)

LEASES (Tables)	6 Months Ended
	Jun. 30, 2020
Leases [Abstract]
Assets and Liabilities, Lessee	Classification June 30, 2020 December 31, 2019 Assets Operating right-of-use assets Right-of-use asset $ 160.1 $ 175.4 Finance right-of-use assets Property, Plant and Equipment 1.9 2.4 Total right-of-use assets 162.0 177.8 Liabilities Current Operating lease liabilities Other accrued liabilities $ 44.3 $ 45.7 Finance lease liabilities Other accrued liabilities .6 1.0 Total current lease liabilities 44.9 46.7 Noncurrent Operating lease liabilities Long-term operating lease liability $ 129.3 $ 143.3 Finance lease liabilities Long-term debt 1.5 1.4 Total noncurrent lease liabilities $ 130.8 $ 144.7 Total lease liability $ 175.7 $ 191.4
Lease Cost	The table below shows the lease income and expenses recorded in the Consolidated Statement of Operations incurred during the three and six months ended June 30, 2020 and 2019. Three months ended June 30, Six months ended June 30, Lease Costs Classification 2020 2019 2020 2019 Operating lease cost (1) Selling, general and administrative expenses $ 15.8 $ 16.6 $ 31.8 $ 33.3 Finance lease cost Amortization of right-of-use assets Selling, general and administrative expenses .3 .4 .6 .9 Interest on lease liabilities Interest Expense .1 .1 .1 .2 Short-term leases costs Selling, general and administrative expenses .6 .8 1.2 1.9 Sublease income (2) Selling, general and administrative expenses (4.5) (2.6) (8.6) (5.8) Net lease cost $ 12.3 $ 15.3 $ 25.1 $ 30.5 (1) Includes variable lease costs which are immaterial. These are presented in selling, general and administrative expenses in our Consolidated Statements of Operations.
Operating Lease Maturity Analysis	The maturity analysis of the finance and operating lease liabilities is reflected below. This table also reflects the reconciliation of the undiscounted cash flows to the discounted finance and operating lease liabilities as recognized in the June 30, 2020 Consolidated Balance Sheet: Maturity of Lease Liabilities Operating Leases Finance Leases Total 2020 $ 32.4 $ .4 $ 32.8 2021 52.9 .9 53.8 2022 44.9 .7 45.6 2023 29.7 .2 29.9 2024 21.2 .1 21.3 2025 18.3 — 18.3 Thereafter 12.1 — 12.1 Total lease payments $ 211.5 $ 2.3 $ 213.8 Less: Interest (37.9) (.2) (38.1) Present value of lease liabilities $ 173.6 $ 2.1 $ 175.7 At December 31, 2019 our operating and finance lease obligations by due dates were as follows: Maturity of Lease Liabilities Operating Leases Finance Leases Total 2020 59.7 1.2 60.9 2021 50.5 .9 51.4 2022 42.4 .6 43.0 2023 28.3 .1 28.4 2024 20.2 — 20.2 Thereafter 30.1 — 30.1 Total lease payments $ 231.2 $ 2.8 $ 234.0 Less: Interest (42.2) (.4) (42.6) Present value of lease liabilities $ 189.0 $ 2.4 $ 191.4
Finance Lease Maturity Analysis	The maturity analysis of the finance and operating lease liabilities is reflected below. This table also reflects the reconciliation of the undiscounted cash flows to the discounted finance and operating lease liabilities as recognized in the June 30, 2020 Consolidated Balance Sheet: Maturity of Lease Liabilities Operating Leases Finance Leases Total 2020 $ 32.4 $ .4 $ 32.8 2021 52.9 .9 53.8 2022 44.9 .7 45.6 2023 29.7 .2 29.9 2024 21.2 .1 21.3 2025 18.3 — 18.3 Thereafter 12.1 — 12.1 Total lease payments $ 211.5 $ 2.3 $ 213.8 Less: Interest (37.9) (.2) (38.1) Present value of lease liabilities $ 173.6 $ 2.1 $ 175.7 At December 31, 2019 our operating and finance lease obligations by due dates were as follows: Maturity of Lease Liabilities Operating Leases Finance Leases Total 2020 59.7 1.2 60.9 2021 50.5 .9 51.4 2022 42.4 .6 43.0 2023 28.3 .1 28.4 2024 20.2 — 20.2 Thereafter 30.1 — 30.1 Total lease payments $ 231.2 $ 2.8 $ 234.0 Less: Interest (42.2) (.4) (42.6) Present value of lease liabilities $ 189.0 $ 2.4 $ 191.4
Lease Terms	The Company has calculated the weighted-average remaining lease term, presented in years below, and the weighted-average discount rate for our operating and finance lease population. The Company uses the incremental borrowing rate as the lease discount rate. Lease Term and Discount Rate June 30, 2020 December 31, 2019 Weighted-average remaining lease term (years) Operating leases 4.5 4.8 Finance leases 2.5 2.6 Weighted-average discount rate Operating leases 8.8 % 8.5 % Finance leases 12.5 % 11.2 %
Cash Flow Classification	The table below sets out the classification of lease payments in the Consolidated Statement of Cash Flows. The right-of-use assets obtained in exchange for new finance and operating lease liabilities represent the new operating and finance leases entered into during the three and six months ended June 30, 2020. Three months ended June 30, Six months ended June 30, Other Information 2020 2019 2020 2019 Operating cash flows from operating leases $ 15.7 $ 15.8 $ 31.8 $ 32.1 Operating cash flows from finance leases .1 — .1 — Financing cash flows from finance leases .2 .3 .6 .7 Cash paid for amounts included in measurement of liabilities $ 16.0 $ 16.1 $ 32.5 $ 32.8 Right-of-use assets obtained in exchange for new finance liabilities $ .1 $ .1 $ .2 $ .9 Right-of-use assets obtained in exchange for new operating liabilities $ .8 $ 8.0 $ 12.8 $ 20.0

EMPLOYEE BENEFIT PLANS (Tables)

EMPLOYEE BENEFIT PLANS (Tables)	6 Months Ended
	Jun. 30, 2020
Retirement Benefits, Description [Abstract]
Schedule of Components of Net Periodic Benefit Cost	Three Months Ended June 30, Pension Benefits Net Periodic Benefit Costs U.S. Plans Non-U.S. Plans Postretirement Benefits 2020 2019 2020 2019 2020 2019 Service cost (1) $ .4 $ .5 $ 1.0 $ 1.0 $ — $ — Interest cost .4 .6 2.8 3.8 .2 .3 Expected return on plan assets (.7) (.8) (3.8) (7.7) — — Amortization of prior service credit — — — — (.1) — Amortization of net actuarial losses .8 .7 1.5 1.3 — — Settlements/curtailments — — — — — — Net periodic benefit costs (1) $ .9 $ 1.0 $ 1.5 $ (1.6) $ .1 $ .3 Six Months Ended June 30, Pension Benefits Net Periodic Benefit Costs U.S. Plans Non-U.S. Plans Postretirement Benefits 2020 2019 2020 2019 2020 2019 Service cost (1) $ .8 $ 1.0 $ 2.1 $ 2.0 $ — $ — Interest cost .8 1.2 5.8 7.7 .3 .6 Expected return on plan assets (1.4) (1.6) (7.9) (15.6) — — Amortization of prior service credit — — — — — — Amortization of net actuarial losses 1.6 1.4 3.1 2.6 — — Settlements/curtailments — — — .1 — — Net periodic benefit costs (1) $ 1.8 $ 2.0 $ 3.1 $ (3.2) $ .3 $ .6

ACCUMULATED OTHER COMPREHENSI_2

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)	6 Months Ended
	Jun. 30, 2020
Equity [Abstract]
Schedule of Amounts in Accumulated Other Comprehensive Income (Loss)	The tables below present the changes in AOCI by component and the reclassifications out of AOCI for the three and six months ended June 30, 2020 and 2019: Three Months Ended June 30, 2020 Foreign Currency Translation Adjustments Cash Flow Hedges Net Investment Hedges Pension and Postretirement Benefits Total Balance at March 31, 2020 $ (1,049.6) $ — $ (4.3) $ (90.4) $ (1,144.3) Other comprehensive loss other than reclassifications (3.5) — — — (3.5) Reclassifications into earnings: Amortization of net actuarial loss and prior service cost, net of tax of $0.2 (1) — — — 2.0 2.0 Total reclassifications into earnings — — — 2.0 2.0 Balance at June 30, 2020 $ (1,053.1) $ — $ (4.3) $ (88.4) $ (1,145.8) Three Months Ended June 30, 2019 Foreign Currency Translation Adjustments Cash Flow Hedges Net Investment Hedges Pension and Postretirement Benefits Investment in New Avon (2) Total Balance at March 31, 2019 $ (939.6) $ (1.4) $ (4.3) $ (92.5) $ 3.4 $ (1,034.4) Other comprehensive income (loss) other than reclassifications 4.4 (1.0) — — — 3.4 Reclassifications into earnings: Derivative loss on cash flow hedges, net of tax of $0.0 — .3 — — — .3 Amortization of net actuarial loss and prior service cost, net of tax of $0.2 1) — — — 1.8 — 1.8 Total reclassifications into earnings — .3 — 1.8 — 2.1 Balance as June 30, 2019 $ (935.2) $ (2.1) $ (4.3) $ (90.7) $ 3.4 $ (1,028.9) Six Months Ended June 30, 2020 Foreign Currency Translation Adjustments Cash Flow Hedges Net Investment Hedges Pension and Postretirement Benefits Total Balance at December 31, 2019 $ (942.7) $ (.6) $ (4.3) $ (92.4) $ (1,040.0) Other comprehensive loss other than reclassifications (110.4) — — — (110.4) Reclassifications into earnings: Derivative losses on cash flow hedges, net of tax of $0.0 — .6 — — .6 Amortization of net actuarial loss and prior service cost, net of tax of $0.4 (1) — — — 4.0 4.0 Total reclassifications into earnings — .6 — 4.0 4.6 Balance at June 30, 2020 $ (1,053.1) $ — $ (4.3) $ (88.4) $ (1,145.8) Six Months Ended June 30, 2019 Foreign Currency Translation Adjustments Cash Flow Hedges Net Investment Hedges Pension and Postretirement Benefits Investment in New Avon (2) Total Balance at December 31, 2018 $ (936.2) $ .5 $ (4.3) $ (93.8) $ 3.4 $ (1,030.4) Other comprehensive (loss) other than reclassifications 1.0 (3.4) — — — (2.4) Reclassifications into earnings: Derivative loss on cash flow hedges, net of tax of $0.0 — .8 — — — .8 Amortization of net actuarial loss and prior service cost, net of tax of $0.4 1) — — — 3.1 — 3.1 Total reclassifications into earnings — .8 — 3.1 — 3.9 Balance as June 30, 2019 $ (935.2) $ (2.1) $ (4.3) $ (90.7) $ 3.4 $ (1,028.9) For further details on Other Comprehensive loss other than reclassifications see the Consolidated Statement of Comprehensive Loss. (1) Gross amount reclassified to other income (expense), net in our Consolidated Statements of Operations, and related taxes reclassified to income taxes in our Consolidated Statements of Operations.

SEGMENT INFORMATION (Tables)

SEGMENT INFORMATION (Tables)	6 Months Ended
	Jun. 30, 2020
Segment Reporting [Abstract]
Schedule of Total Revenue	Summarized financial information concerning our reportable segments was as follows: Three Months Ended June 30, Six Months Ended June 30, Total Revenue 2020 2019 2020 2019 Avon International $ 305.0 $ 534.1 $ 782.1 $ 1,108.8 Avon Latin America 299.7 640.7 779.9 1,252.9 Total revenue from reportable segments (1) 604.7 1,174.8 1,562.0 2,361.7 Revenue from affiliates to Natura &Co 1.8 — 1.8 — Total revenue (1) 606.5 1,174.8 1,563.8 2,361.7
Schedule of Operating Profit	Three Months Ended June 30, Six Months Ended June 30, Operating Profit 2020 2019 2020 2019 Segment Profit Avon International $ (4.4) $ 44.5 $ (1.7) $ 94.5 Avon Latin America (50.8) 53.8 (68.0) 66.5 Total profit from reportable segments (2) $ (55.2) $ 98.3 $ (69.7) $ 161.0 Unallocated global expenses (3) (1.8) (9.0) (1.8) (18.0) Certain Brazil Indirect taxes (5) 10.6 — 10.6 — CTI restructuring initiatives (3.4) (45.7) (5.2) (99.2) Other expenses (4) (.3) (13.1) (85.8) (17.2) Operating profit $ (50.1) $ 30.5 $ (151.9) $ 26.6 (1) Total revenue also includes revenue from other operating segments and business activities of $2.4 and $4.5 for the three months ended June 30, 2020 and 2019 and $8.8 and $10.0 for the six months ended June 30, 2020 and 2019, respectively, allocated to Avon International and Avon Latin America segments. Other operating segments and business activities include revenue from the sale of products to New Avon since the separation of the Company’s North America business into New Avon on March 1, 2016 and ongoing royalties from the licensing of our name and products. Previously reported amount has been allocated to Avon International and Avon Latin America segments to conform to the current year presentation. (2) Total profit from reportable segments also includes profit from other operating segments and business activities and central expenses allocated to Avon International and Avon Latin America segments. Other operating segments and business activities of $1.2 and $.5 for the three months ended June 30, 2020 and 2019 and $4.1 and $1.1 for the six months ended June 30, 2020 and 2019, respectively, include profit from the sale of products to New Avon since the separation of the Company’s North America business into New Avon on March 1, 2016 and ongoing royalties from the licensing of our name and products. Central expenses of $39.3 and $65.3 for the three months ended June 30, 2020 and 2019 and $103.0 and $128.4 for the six months ended June 30, 2020 and 2019, respectively, include corporate general and administrative expenses allocated to Avon International and Avon Latin America to the extent they support the operating activity of the segment. Previously reported amounts has been allocated to segments to conform to the current year presentation. (3) For the three and six months ended June 30, 2020 unallocated global expenses include primarily stewardship and other expenses not directly attributable to reportable segments. (4) For the six months ended June 30, 2020, other expenses include primarily professional fees incurred in relation to the Transaction of approximately $44, severance payments of approximately $25 and acceleration of share based compensation of approximately $10 relating to these terminations triggered by change in control provisions. Refer to Note 19, Mergers with Natura Cosméticos S.A., to the Consolidated Financial Statements contained herein for more information relating to the Transaction. (5) The three and six-month periods ended June 30, 2020 include the impact of certain Brazil indirect taxes, which were recorded in selling, general and administrative expenses, net in the amounts of approximately $11 .

SUPPLEMENTAL BALANCE SHEET IN_2

SUPPLEMENTAL BALANCE SHEET INFORMATION (Tables)	6 Months Ended
	Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Components of Prepaid Expenses and Other	At June 30, 2020 and December 31, 2019, prepaid expenses and other included the following: Components of Prepaid Expenses and Other June 30, 2020 December 31, 2019 Prepaid taxes and tax refunds receivable $ 122.3 $ 141.1 Receivables other than trade (1) 70.9 51.4 Prepaid brochure costs, paper and other literature 11.2 13.1 Other 36.1 46.5 Prepaid expenses and other $ 240.5 $ 252.1
Schedule of Components of Other Assets	At June 30, 2020 and December 31, 2019, other assets included the following: Components of Other Assets (1) June 30, 2020 December 31, 2019 Net overfunded pension plans $ 96.0 $ 100.6 Capitalized software 71.6 83.1 Judicial deposits 48.5 70.1 Long-term receivables 161.8 196.1 Trust assets associated with supplemental benefit plans 35.8 37.3 Other 24.3 27.6 Other assets $ 438.0 $ 514.8 (1) As of June 30, 2020 and December 31, 2019, the Company had tooling, net of amortization of $8.4 and $12.9, respectively. Tooling balance as of December 31, 2019 previously included in other long-term assets has been reclassified to property, plant and equipment to conform to the current year presentation.

RESTRUCTURING INITIATIVES (Tabl

RESTRUCTURING INITIATIVES (Tables)	6 Months Ended
	Jun. 30, 2020
Restructuring and Related Activities [Abstract]
Summary of Restructuring and Related Costs	The costs during the three and six months ended June 30, 2020 and 2019 consisted of the following: Three Months Ended June 30, Six Months Ended June 30, 2020 2019 2020 2019 CTI recorded in operating profit - COGS Manufacturing asset write-offs $ — $ 6.0 $ — $ 9.8 Inventory write-off (.2) 2.6 (.3) 3.1 (.2) 8.6 (.3) 12.9 CTI recorded in operating profit - SG&A Net charges for employee-related costs, including severance benefits .6 13.4 (1.7) 48.6 Implementation costs, primarily related to professional service fees 1.2 17.3 .7 26.0 Dual running costs .7 2.6 1.5 4.5 Contract termination and other net benefits .7 1.4 3.0 4.6 Impairment of other assets — 2.3 .7 2.3 Accelerated depreciation — .1 .4 .3 Variable lease charges .4 — .9 — 3.6 37.1 5.5 86.3 CTI recorded in operating profit 3.4 45.7 5.2 99.2 CTI recorded in other (expense) income (Gain) loss on sale of business / assets (.1) (13.2) (.1) (23.5) Total CTI $ 3.3 $ 32.5 $ 5.1 $ 75.7 Avon Integration $ 1.5 $ — $ 1.5 Open Up & Grow $ 2.0 $ 28.3 $ 6.9 $ 73.4 Transformation Plan $ (.2) $ 4.2 $ (3.3) $ 2.2 Other $ — $ — $ — $ .1
Schedule of Restructuring Reserve	The liability ba lance included in other accrued liabilities in our Consolidated Balance Sheet for the restructuring actions associated with Open Up & Grow at June 30, 2020 is as follows: Employee-Related Costs Inventory/Assets Write-offs Contract Terminations/Other Total Balance at December 31, 2019 $ 17.8 $ — $ 6.4 $ 24.2 2020 charges 1.2 .4 2.6 4.2 Adjustments (1.4) — .4 (1.0) Cash payments (7.8) — (6.6) (14.4) Non-cash write-offs — (.4) — (.4) Foreign exchange (.8) — — (.8) Balance at June 30, 2020 $ 9.0 $ — $ 2.8 $ 11.8 The liability balance included in other accrued liabilities in our Consolidated Balance Sheet for the restructuring actions associated with our Transformation Plan as of June 30, 2020 is as follows: Employee-Related Costs Contract Terminations/Other Total Balance at December 31, 2019 $ 8.4 $ 1.5 $ 9.9 2020 charges — — — Adjustments (2.9) — (2.9) Cash payments (1.9) (1.3) (3.2) Foreign exchange (.1) (.1) (.2) Balance at June 30, 2020 $ 3.5 $ .1 $ 3.6
Schedule of Restructuring Charges Reportable by Business Segment	The following table presents the restructuring charges incurred to date, under, Avon Integration, Open Up & Grow (formerly Open Up Avon) and the Transformation Plan, along with the estimated charges expected to be incurred on approved initiatives under the plans: Employee- Related Costs Inventory/ Asset Write-offs Contract Foreign Currency Translation Adjustment Write-offs Total Avon Integration Charges incurred to-date $ 1.5 $ — $ — $ — $ 1.5 Estimated charges to be incurred on approved initiatives — — — — — Total expected charges on approved initiatives $ 1.5 $ — $ — $ — $ 1.5 Open Up & Grow Charges incurred to-date $ 83.4 $ 107.9 $ 11.5 $ (10.9) $ 191.9 Estimated charges to be incurred on approved initiatives — — 2.5 $ — 2.5 Total expected charges on approved initiatives $ 83.4 $ 107.9 $ 14.0 $ (10.9) $ 194.4 Transformation Plan Charges incurred to-date $ 124.1 $ 2.5 $ 40.9 $ 3.4 $ 170.9 Estimated charges to be incurred on approved initiatives — — — — — Total expected charges on approved initiatives $ 124.1 $ 2.5 $ 40.9 $ 3.4 $ 170.9 The charges, net of adjustments, of initiatives under the Open Up Avon and the Transformation Plan, along with the estimated charges expected to be incurred on approved initiatives under the plans, by reportable segment are as follows: Avon International* Avon Latin America* Global & Other Operating Segments Total Avon Integration Second quarter 2020 .3 — 1.2 1.5 Charges incurred to-date .3 — 1.2 1.5 Estimated charges to be incurred on approved initiatives — — — — Total expected charges on approved initiatives $ .3 $ — $ 1.2 $ 1.5 Open Up & Grow 2018 $ 46.6 $ 64.3 $ 6.2 $ 117.1 2019 19.4 36.9 15.3 71.6 First quarter 2020 3.5 (.1) .2 3.6 Second quarter 2020 (1.0) (.1) .7 (.4) Charges incurred to-date 68.5 101.0 22.4 191.9 Estimated charges to be incurred on approved initiatives 2.5 — — 2.5 Total expected charges on approved initiatives $ 71.0 $ 101.0 $ 22.4 $ 194.4 Transformation Plan 2015 $ — $ — $ 21.4 $ 21.4 2016 40.0 17.6 16.8 74.4 2017 .4 5.0 49.4 54.8 2018 5.6 4.7 13.4 23.7 2019 (1.3) .6 .3 (.4) First quarter 2020 .1 .1 (3.0) (2.8) Second quarter 2020 (.2) — — (.2) Charges incurred to-date 44.6 28.0 98.3 170.9 Estimated charges to be incurred on approved initiatives — — — — Total expected charges on approved initiatives $ 44.6 $ 28.0 $ 98.3 $ 170.9

GOODWILL (Tables)

GOODWILL (Tables)	6 Months Ended
	Jun. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Avon International Avon Latin America Total Net balance at December 31, 2019 * $ 20.0 $ 66.2 $ 86.2 Changes during the period ended June 30, 2020: Foreign exchange (1.0) (8.3) (9.3) Net balance at June 30, 2020 $ 19.0 $ 57.9 $ 76.9 *In January 2020 the Company became a fully owned subsidiary of Natura &Co Holding. As a result of this transaction, the Company has updated its reportable segments to align with Natura &Co Holding operations. Previously reported segment information has been recast throughout the financial statements, as applicable, for all periods presented to reflect the changes in the Company’s reportable segments. Refer to Note 10, Segment Information, to the Consolidated Financial Statements contained herein for more information.

FAIR VALUE (Tables)

FAIR VALUE (Tables)	6 Months Ended
	Jun. 30, 2020
Fair Value Disclosures [Abstract]
Fair Value of Assets and Liabilities Measured on a Recurring Basis	The following table presents the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis as of June 30, 2020: Level 1 Level 2 Total Assets: Available-for-sale securities $ 4.2 $ — $ 4.2 Foreign exchange forward contracts $ — $ 2.7 $ 2.7 Total $ 4.2 $ 2.7 $ 6.9 Liabilities: Foreign exchange forward contracts $ — $ 10.1 $ 10.1 Total $ — $ 10.1 $ 10.1 The following table presents the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis as of December 31, 2019: Level 1 Level 2 Total Assets: Available-for-sale securities $ 4.3 $ — $ 4.3 Foreign exchange forward contracts $ — $ 5.6 $ 5.6 Total $ 4.3 $ 5.6 $ 9.9 Liabilities: Foreign exchange forward contracts $ — $ 3.8 $ 3.8 Total $ — $ 3.8 $ 3.8
Summary of Carrying Value and Fair Value of Financial Instruments	The net asset (liability) amounts recorded in the balance sheet (carrying amount) and the estimated fair values of our remaining financial instruments at June 30, 2020 and December 31, 2019, respectively, consisted of the following: June 30, 2020 December 31, 2019 Carrying Fair Carrying Fair Available-for-sale securities $ 4.2 $ 4.2 $ 4.3 $ 4.3 Debt maturing within one year (28.2) (28.2) (1.8) (1.8) Long-term debt (1) (1,593.1) (1,634.3) (1,590.4) (1,748.1) Foreign exchange forward contracts (7.4) (7.4) 1.8 1.8 (1) The carrying value of long-term debt is presented net of debt issuance costs and includes any related discount or premium.

DERIVATIVE INSTRUMENTS AND HE_2

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)	6 Months Ended
	Jun. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Fair Value of Derivative Instruments	The following table presents the fair value of derivative instruments at June 30, 2020: Asset Liability Balance Sheet Fair Balance Sheet Fair Derivatives not designated as hedges: Foreign exchange forward contracts Prepaid expenses and other $ 2.7 Accounts payable $ 10.1 Total derivatives $ 2.7 $ 10.1 Derivatives are recognized in the Consolidated Balance Sheets at their fair values. The following table presents the fair value of derivative instruments at December 31, 2019: Asset Liability Balance Sheet Fair Balance Sheet Fair Derivatives designated as hedges: Foreign exchange forward contracts Prepaid expenses and other $ — Accounts payable $ .6 Derivatives not designated as hedges: Foreign exchange forward contracts Prepaid expenses and other $ 5.6 Accounts payable $ 3.2 Total derivatives $ 5.6 $ 3.8

ACCOUNTING POLICIES (Details)

ACCOUNTING POLICIES (Details) $ in Millions	3 Months Ended	6 Months Ended	12 Months Ended
	Jun. 30, 2020USD ($)	Jun. 30, 2020USD ($)segment	Dec. 31, 2019USD ($)segment	Mar. 31, 2020USD ($)	[1]	Jun. 30, 2019USD ($)	Mar. 31, 2019USD ($)	Dec. 31, 2018USD ($)
Property, Plant and Equipment [Line Items]
Number of reportable segments | segment		2	4
Property, plant and equipment, net	$ 420.9	$ 420.9	$ 488
Property, plant and equipment, at cost	1,086.6	1,086.6	1,203
Accumulated depreciation	665.7	$ 665.7	715
Revenue shift	87
Accounting Standards Update [Extensible List]		us-gaap:AccountingStandardsUpdate201613Member
Decrease in retained earnings	879.5	$ 879.5	983.8	$ 785.3		$ 957.3	$ 941.5	$ 896.8
Cumulative effect adjustment
Property, Plant and Equipment [Line Items]
Decrease in retained earnings			2
Retained Earnings [Member] | Cumulative effect adjustment
Property, Plant and Equipment [Line Items]
Decrease in retained earnings			2
Tooling
Property, Plant and Equipment [Line Items]
Property, plant and equipment, net	$ 8.4	$ 8.4	12.9
Property, plant and equipment, at cost			94.4
Accumulated depreciation			$ 81.5
[1]	The number of shares of Common Stock (par value $0.01 per share) outstanding at June 30, 2020 was 101.34.

DISCONTINUED OPERATIONS, ASSE_3

DISCONTINUED OPERATIONS, ASSETS AND LIABILITIES HELD FOR SALE AND DIVESTITURES - Additional Information (Details) $ in Millions

Jun. 26, 2019USD ($)

May 09, 2019USD ($)

Feb. 15, 2019USD ($)

Jun. 30, 2020USD ($)property

Apr. 30, 2020USD ($)

Mar. 31, 2020USD ($)

Jun. 30, 2020USD ($)property

Mar. 31, 2020USD ($)property

Jun. 30, 2019USD ($)

Mar. 31, 2019USD ($)

Jun. 30, 2020USD ($)property

Jun. 30, 2019USD ($)

Dec. 31, 2019USD ($)property

Mar. 01, 2016

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Number of properties held for sale | property

5

Net proceeds from sale of business / assets

$ 10

$ 76.5

Gain on sale of business/assets

$ 0.1

$ 13.2

$ 0.1

23.5

Held for sale liabilities

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Carrying value of property previously held for sale

$ 9.1

Avon Manufacturing (Guangzhou), Ltd.

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Net proceeds from sale of business / assets

$ 46.4

Gain on sale of business/assets

$ 10.3

Restricted cash

$ 7.5

Gain on sale, net of tax

8.2

Avon Manufacturing (Guangzhou), Ltd. | TheFaceShop Co., LTd.

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Sale purchase price

$ 71

Acquisition expenses

1.1

Loans assumed

$ 23.5

Avon International

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Number of properties held for sale | property

2

2

2

Number of properties, previously held for sale | property

1

Avon Latin America

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Number of properties held for sale | property

1

1

1

Number of properties, previously held for sale | property

1

Avon Latin America | Held for sale liabilities

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Carrying value of property previously held for sale

$ 3

Hungary Distribution Center in Gödöllő

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Net proceeds from sale of business / assets

$ 3.1

$ 3.4

Deposit

$ 0.3

Gain on sale of business/assets

0.1

China Wellness Plant

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Net proceeds from sale of business / assets

$ 6.6

$ 6.6

Restricted cash

$ 3.3

$ 3.3

$ 3.3

Rye Office

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Net proceeds from sale of business / assets

$ 22.4

Sale purchase price

23.2

Gain on sale of business/assets

9.9

Acquisition expenses

$ 0.8

Asset adjustment

$ 0.2

Malaysia Maximin

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Net proceeds from sale of business / assets

$ 7.6

Sale purchase price

$ 7.8

Gain on sale of business/assets

3.3

Asset adjustment

1.4

$ 1.4

Gain on sale, net of tax

$ 3

New Avon

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Percentage of ownership

19.90%

DISCONTINUED OPERATIONS, ASSE_4

DISCONTINUED OPERATIONS, ASSETS AND LIABILITIES HELD FOR SALE AND DIVESTITURES - Major Classes of Financial Statement Components Comprising the Loss on Discontinued Operations, Net of Tax in North America (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Held for Sale
Disposal Group, Including Discontinued Operation, Assets, Current [Abstract]
Property, Plant and Equipment (net)	$ 12.3		$ 12.3		$ 22.6
New Avon | Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Selling, general and administrative expenses	5.1	$ 13.2	9.8	$ 22.7
Operating loss	(5.1)	(13.2)	(9.8)	(22.7)
Loss from discontinued operations, net of tax	$ (5.1)	$ (13.2)	$ (9.8)	$ (22.7)

RELATED PARTY TRANSACTIONS (Sum

RELATED PARTY TRANSACTIONS (Summary of Related Parties) (Details) $ / shares in Units, R$ in Millions, $ in Millions, $ in Millions	Dec. 30, 2019$ / sharesshares	Jan. 31, 2020USD ($)$ / shares	Jun. 30, 2020USD ($)$ / shares	Jun. 30, 2019USD ($)	Jun. 30, 2018BRL (R$)installment	Jun. 30, 2020USD ($)$ / shares	Jun. 30, 2019USD ($)	Jun. 30, 2020ARS ($)	Dec. 31, 2019USD ($)$ / shares
Related Party Transaction [Line Items]
Revenue from related parties			$ 1.8	$ 0		$ 1.8	$ 0
Loan term						5 years
Shares converted (in shares) | shares	435,000
Converted Series C Convertible Preferred Stock (in shares) | shares	87,000,000
Common stock (in dollars per share) | $ / shares	$ 0.25	$ 0.01	$ 0.01			$ 0.01			$ 0.25
Affiliates of Natura&Co
Related Party Transaction [Line Items]
Dividends		$ 91.5
New Avon | Manufacturing and Supply Agreement
Related Party Transaction [Line Items]
Revenue from related parties				3.7			8.5
Gross profit from sale of product				0			0.1
Cost of sales for purchases from New Avon				0.8			1.5
Purchases from related party				0.6			1.4
New Avon | Transition Services, Intellectual Property, Technical Support and Innovation and Subleases
Related Party Transaction [Line Items]
Selling, general and administrative expenses related to New Avon				(0.1)			(0.2)
New Avon | Project Management Agreement
Related Party Transaction [Line Items]
Selling, general and administrative expenses related to New Avon				(2.1)			(3.4)
Affiliates of Natura&Co
Related Party Transaction [Line Items]
Interest expense on loan from Natura & Co			$ (0.3)	0		$ (0.3)	0
Receivables due from related party			1.9			1.9			$ 0
Payables due to related parties			91.5			91.5			0
Loan from Natura &Co			4.6			4.6		$ 300	0
Affiliates of Natura&Co | Manufacturing and Supply Agreement
Related Party Transaction [Line Items]
Revenue from related parties			1.8	0		1.8	0
Gross profit from sale of product			0.4	0		0.4	0
Instituto Avon
Related Party Transaction [Line Items]
Interest income from Instituto Avon			0	$ 0.1		0	$ 0.1
Receivables due from related party			$ 1.2			$ 1.2			2.1
Cerberus
Related Party Transaction [Line Items]
Payables due to related parties									$ 2.1
Affiliated entity | Loan to Related Party | Instituto Avon
Related Party Transaction [Line Items]
Loan amount | R$					R$ 12
Loan interest rate					7.00%
Number of loan annual installments | installment					5

REVENUE Disaggregation of Reven

REVENUE Disaggregation of Revenues (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Disaggregation of Revenue [Line Items]
Revenue		$ 1,174.8		$ 2,361.7
Revenue from affiliates of Natura &Co	$ 1.8	0	$ 1.8	0
Total revenue	606.5	1,174.8	1,563.8	2,361.7
Beauty
Disaggregation of Revenue [Line Items]
Revenue		829.8		1,666.3
Total revenue	440.9		1,134.6
Beauty - Skincare
Disaggregation of Revenue [Line Items]
Revenue		345.9		695.2
Total revenue	216.2		512.8
Beauty - Fragrance
Disaggregation of Revenue [Line Items]
Revenue		303.1		601.1
Total revenue	149.5		397.8
Beauty - Color
Disaggregation of Revenue [Line Items]
Revenue		180.8		370
Total revenue	75.2		224
Fashion And Home
Disaggregation of Revenue [Line Items]
Revenue		279		558.7
Total revenue	132.2		338.3
Fashion & Home - Fashion
Disaggregation of Revenue [Line Items]
Revenue		156.2		320.5
Total revenue	65.3		181.4
Fashion & Home - Home
Disaggregation of Revenue [Line Items]
Revenue		122.8		238.2
Total revenue	66.9		156.9
Net Sales
Disaggregation of Revenue [Line Items]
Revenue	573.1	1,108.8	1,472.9	2,225
Total revenue	573.1		1,472.9
Other revenue
Disaggregation of Revenue [Line Items]
Revenue		66		136.7
Total revenue	33.4		90.9
Other - Representative Fees
Disaggregation of Revenue [Line Items]
Revenue		61.7		125.6
Total revenue	29.2		80.1
Other - Other Product And Services
Disaggregation of Revenue [Line Items]
Revenue		4.3		11.1
Total revenue	4.2		10.8
Operating Segments
Disaggregation of Revenue [Line Items]
Revenue	604.7		1,562
Total revenue	604.7	1,174.8	1,562	2,361.7
Operating Segments | Beauty
Disaggregation of Revenue [Line Items]
Revenue	440.9		1,134.6
Operating Segments | Beauty - Skincare
Disaggregation of Revenue [Line Items]
Revenue	216.2		512.8
Operating Segments | Beauty - Fragrance
Disaggregation of Revenue [Line Items]
Revenue	149.5		397.8
Operating Segments | Beauty - Color
Disaggregation of Revenue [Line Items]
Revenue	75.2		224
Operating Segments | Fashion And Home
Disaggregation of Revenue [Line Items]
Revenue	132.2		338.3
Operating Segments | Fashion & Home - Fashion
Disaggregation of Revenue [Line Items]
Revenue	65.3		181.4
Operating Segments | Fashion & Home - Home
Disaggregation of Revenue [Line Items]
Revenue	66.9		156.9
Operating Segments | Net Sales
Disaggregation of Revenue [Line Items]
Revenue	573.1		1,472.9
Operating Segments | Other revenue
Disaggregation of Revenue [Line Items]
Revenue	31.6		89.1
Operating Segments | Other - Representative Fees
Disaggregation of Revenue [Line Items]
Revenue	29.2		80.1
Operating Segments | Other - Other Product And Services
Disaggregation of Revenue [Line Items]
Revenue	2.4		9
Revenue from affiliates to Natura &Co
Disaggregation of Revenue [Line Items]
Revenue from affiliates of Natura &Co	1.8		1.8
Total revenue	1.8	0	1.8	0
Revenue from affiliates to Natura &Co | Beauty
Disaggregation of Revenue [Line Items]
Revenue from affiliates of Natura &Co	0		0
Revenue from affiliates to Natura &Co | Beauty - Skincare
Disaggregation of Revenue [Line Items]
Revenue from affiliates of Natura &Co	0		0
Revenue from affiliates to Natura &Co | Beauty - Fragrance
Disaggregation of Revenue [Line Items]
Revenue from affiliates of Natura &Co	0		0
Revenue from affiliates to Natura &Co | Beauty - Color
Disaggregation of Revenue [Line Items]
Revenue from affiliates of Natura &Co	0		0
Revenue from affiliates to Natura &Co | Fashion And Home
Disaggregation of Revenue [Line Items]
Revenue from affiliates of Natura &Co	0		0
Revenue from affiliates to Natura &Co | Fashion & Home - Fashion
Disaggregation of Revenue [Line Items]
Revenue from affiliates of Natura &Co	0		0
Revenue from affiliates to Natura &Co | Fashion & Home - Home
Disaggregation of Revenue [Line Items]
Revenue from affiliates of Natura &Co	0		0
Revenue from affiliates to Natura &Co | Net Sales
Disaggregation of Revenue [Line Items]
Revenue from affiliates of Natura &Co	0		0
Revenue from affiliates to Natura &Co | Other revenue
Disaggregation of Revenue [Line Items]
Revenue from affiliates of Natura &Co	1.8		1.8
Revenue from affiliates to Natura &Co | Other - Representative Fees
Disaggregation of Revenue [Line Items]
Revenue from affiliates of Natura &Co	0		0
Revenue from affiliates to Natura &Co | Other - Other Product And Services
Disaggregation of Revenue [Line Items]
Revenue from affiliates of Natura &Co	1.8		1.8
Avon International | Operating Segments
Disaggregation of Revenue [Line Items]
Revenue	305	534.1	782.1	1,108.8
Total revenue	305	534.1	782.1	1,108.8
Avon International | Operating Segments | Beauty
Disaggregation of Revenue [Line Items]
Revenue	246.6	401.8	614.6	832.9
Avon International | Operating Segments | Beauty - Skincare
Disaggregation of Revenue [Line Items]
Revenue	122.6	165.9	273.2	338.2
Avon International | Operating Segments | Beauty - Fragrance
Disaggregation of Revenue [Line Items]
Revenue	78.7	143	211	294.7
Avon International | Operating Segments | Beauty - Color
Disaggregation of Revenue [Line Items]
Revenue	45.3	92.9	130.4	200
Avon International | Operating Segments | Fashion And Home
Disaggregation of Revenue [Line Items]
Revenue	46.2	108.8	132.1	227.1
Avon International | Operating Segments | Fashion & Home - Fashion
Disaggregation of Revenue [Line Items]
Revenue	38.4	95	111.2	198.4
Avon International | Operating Segments | Fashion & Home - Home
Disaggregation of Revenue [Line Items]
Revenue	7.8	13.8	20.9	28.7
Avon International | Operating Segments | Net Sales
Disaggregation of Revenue [Line Items]
Revenue	292.8	510.6	746.7	1,060
Avon International | Operating Segments | Other revenue
Disaggregation of Revenue [Line Items]
Revenue	12.2	23.5	35.4	48.8
Avon International | Operating Segments | Other - Representative Fees
Disaggregation of Revenue [Line Items]
Revenue	11.1	22.7	31.3	47
Avon International | Operating Segments | Other - Other Product And Services
Disaggregation of Revenue [Line Items]
Revenue	1.1	0.8	4.1	1.8
Avon Latin America | Operating Segments
Disaggregation of Revenue [Line Items]
Revenue	299.7	640.7	779.9	1,252.9
Total revenue	299.7	640.7	779.9	1,252.9
Avon Latin America | Operating Segments | Beauty
Disaggregation of Revenue [Line Items]
Revenue	194.3	428	520	833.4
Avon Latin America | Operating Segments | Beauty - Skincare
Disaggregation of Revenue [Line Items]
Revenue	93.6	180	239.6	357
Avon Latin America | Operating Segments | Beauty - Fragrance
Disaggregation of Revenue [Line Items]
Revenue	70.8	160.1	186.8	306.4
Avon Latin America | Operating Segments | Beauty - Color
Disaggregation of Revenue [Line Items]
Revenue	29.9	87.9	93.6	170
Avon Latin America | Operating Segments | Fashion And Home
Disaggregation of Revenue [Line Items]
Revenue	86	170.2	206.2	331.6
Avon Latin America | Operating Segments | Fashion & Home - Fashion
Disaggregation of Revenue [Line Items]
Revenue	26.9	61.2	70.2	122.1
Avon Latin America | Operating Segments | Fashion & Home - Home
Disaggregation of Revenue [Line Items]
Revenue	59.1	109	136	209.5
Avon Latin America | Operating Segments | Net Sales
Disaggregation of Revenue [Line Items]
Revenue	280.3	598.2	726.2	1,165
Avon Latin America | Operating Segments | Other revenue
Disaggregation of Revenue [Line Items]
Revenue	19.4	42.5	53.7	87.9
Avon Latin America | Operating Segments | Other - Representative Fees
Disaggregation of Revenue [Line Items]
Revenue	18.1	39	48.8	78.6
Avon Latin America | Operating Segments | Other - Other Product And Services
Disaggregation of Revenue [Line Items]
Revenue	$ 1.3	$ 3.5	$ 4.9	$ 9.3

REVENUE Assets and Liabilities

REVENUE Assets and Liabilities (Details) - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Revenue from Contract with Customer [Abstract]
Accounts receivable, net of allowances of $57.0 and $66.6	$ 156.9	$ 280.2
Contract liabilities	39.1	51
Accounts receivable, allowances	$ 57	$ 66.6

REVENUE Narrative (Details)

REVENUE Narrative (Details) $ in Millions	6 Months Ended	12 Months Ended
	Jun. 30, 2020USD ($)segment	Dec. 31, 2019segment
Revenue from Contract with Customer [Abstract]
Number of reportable segments | segment	2	4
Performance obligations satisfied	$ 34.5
Material rights	$ 25.9

INVENTORIES (Components of Inve

INVENTORIES (Components of Inventories) (Details) - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Inventory Disclosure [Abstract]
Raw materials	$ 128.8	$ 130.6
Finished goods	307.9	321.7
Inventories	$ 436.7	$ 452.3

LEASES - Balance Sheet Implicat

LEASES - Balance Sheet Implication (Details) - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Assets
Operating right-of-use assets	$ 160.1	$ 175.4
Finance right-of-use assets	1.9	2.4
Total right-of-use assets	162	177.8
Current
Operating lease liabilities	44.3	45.7
Finance lease liabilities	0.6	1
Total current lease liabilities	44.9	46.7
Noncurrent
Operating lease liabilities	129.3	143.3
Finance lease liabilities	1.5	1.4
Total noncurrent lease liabilities	130.8	144.7
Total lease liability	$ 175.7	$ 191.4
Finance lease assets, statement of financial position [Extensible List]	us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
Current operating lease liability, statement of financial position [Extensible List]	us-gaap:AccruedLiabilitiesCurrent	us-gaap:AccruedLiabilitiesCurrent
Current finance lease liability, statement of financial position [Extensible List]	us-gaap:AccruedLiabilitiesCurrent	us-gaap:AccruedLiabilitiesCurrent
Noncurrent finance lease liability, statement of financial position [Extensible List]	us-gaap:LongTermDebtNoncurrent	us-gaap:LongTermDebtNoncurrent

LEASES - Income and Expenses (D

LEASES - Income and Expenses (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Leases [Abstract]
Operating lease cost	$ 15.8	$ 16.6	$ 31.8	$ 33.3
Amortization of right-of-use assets	0.3	0.4	0.6	0.9
Interest on lease liabilities	0.1	0.1	0.1	0.2
Short-term leases costs	0.6	0.8	1.2	1.9
Sublease income	(4.5)	(2.6)	(8.6)	(5.8)
Net lease cost	$ 12.3	$ 15.3	$ 25.1	$ 30.5

LEASES - Maturity of Lease Liab

LEASES - Maturity of Lease Liability (Details) - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Operating Leases
2020	$ 32.4
2021	52.9	$ 59.7
2022	44.9	50.5
2023	29.7	42.4
2024	21.2	28.3
2025	18.3	20.2
Thereafter	12.1	30.1
Total lease payments	211.5	231.2
Less: Interest	(37.9)	(42.2)
Present value of lease liabilities	173.6	189
Finance Leases
2020	0.4
2021	0.9	1.2
2022	0.7	0.9
2023	0.2	0.6
2024	0.1	0.1
2025	0	0
Thereafter	0	0
Total lease payments	2.3	2.8
Less: Interest	(0.2)	(0.4)
Present value of lease liabilities	2.1	2.4
Total
2020	32.8
2021	53.8
2022	45.6	51.4
2023	29.9	43
2023	21.3	28.4
2024	18.3	20.2
Thereafter	12.1	30.1
Total lease payments	213.8	234
Less: Interest	(38.1)	(42.6)
Total lease liability	$ 175.7	$ 191.4

LEASES - Maturity of Lease Li_2

LEASES - Maturity of Lease Liability - Prior Year (Details) - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Operating Leases
2020	$ 52.9	$ 59.7
2021	44.9	50.5
2022	29.7	42.4
2023	21.2	28.3
2024	18.3	20.2
Thereafter	12.1	30.1
Total lease payments	211.5	231.2
Less: Interest	(37.9)	(42.2)
Present value of lease liabilities	173.6	189
Finance Leases
2020	0.9	1.2
2021	0.7	0.9
2022	0.2	0.6
2023	0.1	0.1
2024	0	0
Thereafter	0	0
Total lease payments	2.3	2.8
Less: Interest	0.2	0.4
Present value of lease liabilities	2.1	2.4
Total
2020		60.9
2021	45.6	51.4
2022	29.9	43
2023	21.3	28.4
2024	18.3	20.2
Thereafter	12.1	30.1
Total lease payments	213.8	234
Less: Interest	(38.1)	(42.6)
Total lease liability	$ 175.7	$ 191.4

LEASES - Lease Term and Discoun

LEASES - Lease Term and Discount Rate (Details)	Jun. 30, 2020	Dec. 31, 2019
Leases [Abstract]
Weighted-average remaining lease term, operating leases	4 years 6 months	4 years 9 months 18 days
Weighted-average remaining lease term, finance leases	2 years 6 months	2 years 7 months 6 days
Weighted-average discount rate, operating leases	8.80%	8.50%
Weighted-average discount rate, financing leases	12.50%	11.20%

LEASES - Other Information (Det

LEASES - Other Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Leases [Abstract]
Operating cash flows from operating leases	$ 15.7	$ 15.8	$ 31.8	$ 32.1
Operating cash flows from finance leases	0.1	0	0.1	0
Financing cash flows from finance leases	0.2	0.3	0.6	0.7
Cash paid for amounts included in measurement of liabilities	16	16.1	32.5	32.8
Right-of-use assets obtained in exchange for new finance liabilities	0.1	0.1	0.2	0.9
Right-of-use assets obtained in exchange for new operating liabilities	$ 0.8	$ 8	$ 12.8	$ 20

EMPLOYEE BENEFIT PLANS (Compone

EMPLOYEE BENEFIT PLANS (Components of Net Periodic Benefit Cost) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Postretirement Benefits
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 0	$ 0	$ 0	$ 0
Interest cost	0.2	0.3	0.3	0.6
Expected return on plan assets	0	0	0	0
Amortization of prior service credit	(0.1)	0	0	0
Amortization of net actuarial losses	0	0	0	0
Settlements/curtailments	0	0	0	0
Net periodic benefit costs	0.1	0.3	0.3	0.6
United States | Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Service cost	0.4	0.5	0.8	1
Interest cost	0.4	0.6	0.8	1.2
Expected return on plan assets	(0.7)	(0.8)	(1.4)	(1.6)
Amortization of prior service credit	0	0	0	0
Amortization of net actuarial losses	0.8	0.7	1.6	1.4
Settlements/curtailments	0	0	0	0
Net periodic benefit costs	0.9	1	1.8	2
Non-U.S. Plans | Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Service cost	1	1	2.1	2
Interest cost	2.8	3.8	5.8	7.7
Expected return on plan assets	(3.8)	(7.7)	(7.9)	(15.6)
Amortization of prior service credit	0	0	0	0
Amortization of net actuarial losses	1.5	1.3	3.1	2.6
Settlements/curtailments	0	0	0	0.1
Net periodic benefit costs	$ 1.5	$ (1.6)	$ 3.1	$ (3.2)

EMPLOYEE BENEFIT PLANS (Narrati

EMPLOYEE BENEFIT PLANS (Narrative) (Details) $ in Millions	6 Months Ended
	Jun. 30, 2020USD ($)
Minimum | U.S. Pension and Postretirement Plans
Defined Benefit Plan Disclosure [Line Items]
Estimated contributions for the remainder of fiscal year	$ 0
Maximum | U.S. Pension and Postretirement Plans
Defined Benefit Plan Disclosure [Line Items]
Estimated contributions for the remainder of fiscal year	5
United States
Defined Benefit Plan Disclosure [Line Items]
Employer contribution, approximately	2
Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Employer contribution, approximately	$ 3

CONTINGENCIES (Details)

CONTINGENCIES (Details) $ in Millions	3 Months Ended			6 Months Ended
	Jun. 30, 2020USD ($)	Jun. 30, 2019USD ($)	Sep. 30, 2018USD ($)	Jun. 30, 2020USD ($)lawsuit	Jun. 30, 2019USD ($)	Apr. 18, 2018USD ($)	Oct. 31, 2017USD ($)	Dec. 31, 2012USD ($)
Loss Contingencies [Line Items]
Assessment of contingencies, including penalties and accruing interest, adjustment						$ 47
Revenue		$ 1,174.8			$ 2,361.7
Other expense, net	$ (0.9)	$ 6.8		$ (19.1)	$ 29.4
Number of litigation suits | lawsuit				139
Number of litigation suits, new | lawsuit				11
Number of litigation suits, dismissed | lawsuit				3
Assessment for 2012
Loss Contingencies [Line Items]
Assessment of contingencies, including penalties and accruing interest						$ 179		$ 179
Assessment for 2017
Loss Contingencies [Line Items]
Assessment of contingencies, including penalties and accruing interest							$ 178
IPI Tax on Cosmetics
Loss Contingencies [Line Items]
Estimated litigation liability			$ 195
Revenue			168
Other expense, net			$ 27
Possible loss	203			$ 203
Tax reserve	68			68
Brazil labor-related
Loss Contingencies [Line Items]
Estimated litigation liability	$ 4			4
Shareholder Litigation
Loss Contingencies [Line Items]
Litigation settlement payment				14.5
Settlement payment paid by company				$ 2

ACCUMULATED OTHER COMPREHENSI_3

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Components of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Mar. 01, 2016
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Accumulated other comprehensive income, beginning balance			$ (990.6)
Other comprehensive loss other than reclassifications	$ (3.5)	$ 3.4	(110.4)	$ (2.4)
Reclassifications into earnings:
Derivative losses on cash flow hedges, net of tax		0.3	0.6	0.8
Amortization of net actuarial loss and prior service cost, net of tax	2	1.8	4	3.1
Total reclassifications into earnings	2	2.1	4.6	3.9
Accumulated other comprehensive income, ending balance	(884.5)		(884.5)
Derivative losses on cash flow hedges, tax		0	0	0
Amortization of net actuarial loss and prior service cost, tax	0.2	0.2	0.4	0.4
New Avon
Reclassifications into earnings:
Percentage of ownership					19.90%
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Accumulated other comprehensive income, beginning balance	(1,049.6)	(939.6)	(942.7)	(936.2)
Other comprehensive loss other than reclassifications	(3.5)	4.4	(110.4)	1
Reclassifications into earnings:
Total reclassifications into earnings	0	0	0	0
Accumulated other comprehensive income, ending balance	(1,053.1)	(935.2)	(1,053.1)	(935.2)
Cash Flow Hedges
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Accumulated other comprehensive income, beginning balance	0	(1.4)	(0.6)	0.5
Other comprehensive loss other than reclassifications	0	(1)	0	(3.4)
Reclassifications into earnings:
Derivative losses on cash flow hedges, net of tax		0.3	0.6	0.8
Total reclassifications into earnings	0	0.3	0.6	0.8
Accumulated other comprehensive income, ending balance	0	(2.1)	0	(2.1)
Net Investment Hedges
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Accumulated other comprehensive income, beginning balance	(4.3)	(4.3)	(4.3)	(4.3)
Other comprehensive loss other than reclassifications	0		0
Reclassifications into earnings:
Total reclassifications into earnings	0	0	0	0
Accumulated other comprehensive income, ending balance	(4.3)	(4.3)	(4.3)	(4.3)
Pension and Postretirement Benefits
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Accumulated other comprehensive income, beginning balance	(90.4)	(92.5)	(92.4)	(93.8)
Other comprehensive loss other than reclassifications	0		0
Reclassifications into earnings:
Amortization of net actuarial loss and prior service cost, net of tax	2	1.8	4	3.1
Total reclassifications into earnings	2	1.8	4	3.1
Accumulated other comprehensive income, ending balance	(88.4)	(90.7)	(88.4)	(90.7)
Investment in New Avon
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Accumulated other comprehensive income, beginning balance		3.4		3.4
Reclassifications into earnings:
Total reclassifications into earnings		0		0
Accumulated other comprehensive income, ending balance		3.4		3.4
AOCI Attributable to Parent
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Accumulated other comprehensive income, beginning balance	(1,144.3)	(1,034.4)	(1,040)	(1,030.4)
Reclassifications into earnings:
Accumulated other comprehensive income, ending balance	$ (1,145.8)	$ (1,028.9)	$ (1,145.8)	$ (1,028.9)

ACCUMULATED OTHER COMPREHENSI_4

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Equity [Abstract]
Foreign exchange losses	$ 0.1	$ 2.3	$ 3.9	$ 0.7

SEGMENT INFORMATION (NARRATIVE)

SEGMENT INFORMATION (NARRATIVE) (Details) - segment	6 Months Ended	12 Months Ended
	Jun. 30, 2020	Dec. 31, 2019
Segment Reporting [Abstract]
Number of reportable segments	2	4

SEGMENT INFORMATION (Total Reve

SEGMENT INFORMATION (Total Revenue and Operating Profit by Reporting Segment) (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended		6 Months Ended
	Jan. 31, 2020	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Segment Reporting Information [Line Items]
Total revenue		$ 606.5	$ 1,174.8	$ 1,563.8	$ 2,361.7
Operating profit		(50.1)	30.5	(151.9)	26.6
CTI restructuring initiatives		(3.3)	(32.5)	(5.1)	(75.7)
Other expense, net		(0.9)	6.8	(19.1)	29.4
Royalty expense		39.3	65.3	103	128.4
Merger Agreement
Segment Reporting Information [Line Items]
Acquisition expenses				44
Severance costs	$ 24	25
Accelerated share based compensation	$ 10	10
Reportable segments
Segment Reporting Information [Line Items]
Total revenue		604.7	1,174.8	1,562	2,361.7
Operating profit		(55.2)	98.3	(69.7)	161
All other
Segment Reporting Information [Line Items]
Total revenue		2.4	4.5	8.8	10
Operating profit		1.2	0.5	4.1	1.1
Unallocated Expenses		(1.8)	(9)	(1.8)	(18)
Certain Brazil Indirect taxes		10.6	0	10.6	0
CTI restructuring initiatives		(3.4)	(45.7)	(5.2)	(99.2)
Other expense, net		(0.3)	(13.1)	(85.8)	(17.2)
Revenue from affiliates to Natura &Co
Segment Reporting Information [Line Items]
Total revenue		1.8	0	1.8	0
Avon International | Reportable segments
Segment Reporting Information [Line Items]
Total revenue		305	534.1	782.1	1,108.8
Operating profit		(4.4)	44.5	(1.7)	94.5
Avon Latin America | Reportable segments
Segment Reporting Information [Line Items]
Total revenue		299.7	640.7	779.9	1,252.9
Operating profit		$ (50.8)	$ 53.8	$ (68)	$ 66.5

SUPPLEMENTAL BALANCE SHEET IN_3

SUPPLEMENTAL BALANCE SHEET INFORMATION (Components of Prepaid Expenses and Other) (Details) - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Loans and Leases Receivable Disclosure [Line Items]
Prepaid taxes and tax refunds receivable	$ 122.3	$ 141.1
Receivables other than trade(1)	70.9	51.4
Prepaid brochure costs, paper and other literature	11.2	13.1
Other	36.1	46.5
Prepaid expenses and other	240.5	$ 252.1
Insurance receivables	27
Shareholder Litigation
Loans and Leases Receivable Disclosure [Line Items]
Insurance receivables	12
Contingent liability	$ 15

SUPPLEMENTAL BALANCE SHEET IN_4

SUPPLEMENTAL BALANCE SHEET INFORMATION (Components of Other Assets) (Details) - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Property, Plant and Equipment [Line Items]
Net overfunded pension plans	$ 96	$ 100.6
Capitalized software	71.6	83.1
Judicial deposits	48.5	70.1
Long-term receivables	161.8	196.1
Trust assets associated with supplemental benefit plans	35.8	37.3
Other	24.3	27.6
Other assets	438	514.8
Property, plant and equipment, net	420.9	488
Tooling
Property, Plant and Equipment [Line Items]
Property, plant and equipment, net	$ 8.4	$ 12.9

RESTRUCTURING INITIATIVES - Nar

RESTRUCTURING INITIATIVES - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Restructuring Cost and Reserve [Line Items]
Restructuring charges and other costs	$ 3.3	$ 32.5	$ 5.1	$ 75.7
Avon Integration
Restructuring Cost and Reserve [Line Items]
Restructuring charges and other costs	1.5	0	1.5
Employee-related liabilities	0.7		0.7
Open Up & Grow
Restructuring Cost and Reserve [Line Items]
Restructuring charges and other costs	2	28.3	6.9	73.4
Transformation Plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges and other costs	(0.2)	4.2	(3.3)	2.2
Other Restructuring Initiatives
Restructuring Cost and Reserve [Line Items]
Restructuring charges and other costs	$ 0	$ 0	$ 0	$ 0.1

RESTRUCTURING INITIATIVES - Sum

RESTRUCTURING INITIATIVES - Summary (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives	$ 3.3	$ 32.5	$ 5.1	$ 75.7
Avon Integration
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives	1.5	0	1.5
Open Up & Grow
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives	2	28.3	6.9	73.4
Transformation Plan
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives	(0.2)	4.2	(3.3)	2.2
Other Restructuring Initiatives
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives	0	0	0	0.1
Cost of Goods Sold
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives	(0.2)	8.6	(0.3)	12.9
Cost of Goods Sold | Manufacturing asset write-offs
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives	0	6	0	9.8
Cost of Goods Sold | Inventory write-off
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives	(0.2)	2.6	(0.3)	3.1
Selling, General and Administrative Expense
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives	3.6	37.1	5.5	86.3
Selling, General and Administrative Expense | Net charges for employee-related costs, including severance benefits
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives	0.6	13.4	(1.7)	48.6
Selling, General and Administrative Expense | Implementation costs, primarily related to professional service fees
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives	1.2	17.3	0.7	26
Selling, General and Administrative Expense | Dual running costs
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives	0.7	2.6	1.5	4.5
Selling, General and Administrative Expense | Contract termination and other net benefits
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives	0.7	1.4	3	4.6
Selling, General and Administrative Expense | Impairment of other assets
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives	0	2.3	0.7	2.3
Selling, General and Administrative Expense | Accelerated depreciation
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives	0	0.1	0.4	0.3
Selling, General and Administrative Expense | Variable lease charges
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives	0.4	0	0.9	0
Operating Profit
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives	3.4	45.7	5.2	99.2
Other (Expense) Income | (Gain) loss on sale of business / assets
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives	$ (0.1)	$ (13.2)	$ (0.1)	$ (23.5)

RESTRUCTURING INITIATIVES - OPE

RESTRUCTURING INITIATIVES - OPEN UP AVON (Details) - Open Up & Grow $ in Millions	6 Months Ended
	Jun. 30, 2020USD ($)
Restructuring Reserve [Roll Forward]
Beginning balance	$ 24.2
2020 charges	4.2
Adjustments	(1)
Cash payments	(14.4)
Non-cash write-offs	(0.4)
Foreign exchange	(0.8)
Ending balance	11.8
Employee-Related Costs
Restructuring Reserve [Roll Forward]
Beginning balance	17.8
2020 charges	1.2
Adjustments	(1.4)
Cash payments	(7.8)
Non-cash write-offs	0
Foreign exchange	(0.8)
Ending balance	9
Inventory/Assets Write-offs
Restructuring Reserve [Roll Forward]
Beginning balance	0
2020 charges	0.4
Adjustments	0
Cash payments	0
Non-cash write-offs	(0.4)
Foreign exchange	0
Ending balance	0
Contract Terminations/Other
Restructuring Reserve [Roll Forward]
Beginning balance	6.4
2020 charges	2.6
Adjustments	0.4
Cash payments	(6.6)
Non-cash write-offs	0
Foreign exchange	0
Ending balance	$ 2.8

RESTRUCTURING INITIATIVES - TRA

RESTRUCTURING INITIATIVES - TRANSFORMATION PLAN (Liability Balances) (Details) - Transformation Plan $ in Millions	6 Months Ended
	Jun. 30, 2020USD ($)
Restructuring Reserve [Roll Forward]
Beginning balance	$ 9.9
2020 charges	0
Adjustments	(2.9)
Cash payments	(3.2)
Foreign exchange	(0.2)
Ending balance	3.6
Employee-Related Costs
Restructuring Reserve [Roll Forward]
Beginning balance	8.4
2020 charges	0
Adjustments	(2.9)
Cash payments	(1.9)
Foreign exchange	(0.1)
Ending balance	3.5
Contract Terminations/Other
Restructuring Reserve [Roll Forward]
Beginning balance	1.5
2020 charges	0
Adjustments	0
Cash payments	(1.3)
Foreign exchange	(0.1)
Ending balance	$ 0.1

RESTRUCTURING INITIATIVES (Rest

RESTRUCTURING INITIATIVES (Restructuring Initiatives by Charge Type) (Details) $ in Millions	Jun. 30, 2020USD ($)
Avon Integration
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	$ 1.5
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	1.5
Avon Integration | Employee-Related Costs
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	1.5
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	1.5
Avon Integration | Inventory/Assets Write-offs
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	0
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	0
Avon Integration | Contract Terminations/Other
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	0
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	0
Avon Integration | Foreign Currency Translation Adjustment Write-offs
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	0
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	0
Open Up & Grow
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	191.9
Estimated charges to be incurred on approved initiatives	2.5
Total expected charges on approved initiatives	194.4
Open Up & Grow | Employee-Related Costs
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	83.4
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	83.4
Open Up & Grow | Inventory/Assets Write-offs
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	107.9
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	107.9
Open Up & Grow | Contract Terminations/Other
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	11.5
Estimated charges to be incurred on approved initiatives	2.5
Total expected charges on approved initiatives	14
Open Up & Grow | Foreign Currency Translation Adjustment Write-offs
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	(10.9)
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	(10.9)
Transformation Plan
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	170.9
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	170.9
Transformation Plan | Employee-Related Costs
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	124.1
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	124.1
Transformation Plan | Inventory/Assets Write-offs
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	2.5
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	2.5
Transformation Plan | Contract Terminations/Other
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	40.9
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	40.9
Transformation Plan | Foreign Currency Translation Adjustment Write-offs
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	3.4
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	$ 3.4

RESTRUCTURING INITIATIVES (Char

RESTRUCTURING INITIATIVES (Charges Reportable by Business Segment) (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Avon Integration
Restructuring Cost and Reserve [Line Items]
Charges incurred	$ 1.5
Charges incurred to-date	1.5
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	1.5
Avon Integration | Avon International
Restructuring Cost and Reserve [Line Items]
Charges incurred	0.3
Charges incurred to-date	0.3
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	0.3
Avon Integration | Avon Latin America
Restructuring Cost and Reserve [Line Items]
Charges incurred	0
Charges incurred to-date	0
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	0
Avon Integration | Global & Other Operating Segments
Restructuring Cost and Reserve [Line Items]
Charges incurred	1.2
Charges incurred to-date	1.2
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	1.2
Open Up & Grow
Restructuring Cost and Reserve [Line Items]
Charges incurred	(0.4)	$ 3.6	$ 71.6	$ 117.1
Charges incurred to-date	191.9
Estimated charges to be incurred on approved initiatives	2.5
Total expected charges on approved initiatives	194.4
Open Up & Grow | Avon International
Restructuring Cost and Reserve [Line Items]
Charges incurred	(1)	3.5	19.4	46.6
Charges incurred to-date	68.5
Estimated charges to be incurred on approved initiatives	2.5
Total expected charges on approved initiatives	71
Open Up & Grow | Avon Latin America
Restructuring Cost and Reserve [Line Items]
Charges incurred	(0.1)	(0.1)	36.9	64.3
Charges incurred to-date	101
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	101
Open Up & Grow | Global & Other Operating Segments
Restructuring Cost and Reserve [Line Items]
Charges incurred	0.7	0.2	15.3	6.2
Charges incurred to-date	22.4
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	22.4
Transformation Plan
Restructuring Cost and Reserve [Line Items]
Charges incurred	(0.2)	(2.8)	(0.4)	23.7	$ 54.8	$ 74.4	$ 21.4
Charges incurred to-date	170.9
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	170.9
Transformation Plan | Avon International
Restructuring Cost and Reserve [Line Items]
Charges incurred	(0.2)	0.1	(1.3)	5.6	0.4	40	0
Charges incurred to-date	44.6
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	44.6
Transformation Plan | Avon Latin America
Restructuring Cost and Reserve [Line Items]
Charges incurred	0	0.1	0.6	4.7	5	17.6	0
Charges incurred to-date	28
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	28
Transformation Plan | Global & Other Operating Segments
Restructuring Cost and Reserve [Line Items]
Charges incurred	0	$ (3)	$ 0.3	$ 13.4	$ 49.4	$ 16.8	$ 21.4
Charges incurred to-date	98.3
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	$ 98.3

SERIES C CONVERTIBLE PREFERRE_2

SERIES C CONVERTIBLE PREFERRED STOCK (Details) - USD ($) $ / shares in Units, $ in Millions	Dec. 30, 2019	Mar. 01, 2016	Jan. 31, 2020	Dec. 31, 2019	Jun. 30, 2020
Class of Stock [Line Items]
Dividend rate		1.25%
Dividends payable				$ 8.7	$ 0
Increase in Carrying Amount of Redeemable Preferred Stock				$ 60.9
Shares converted (in shares)	435,000
Common stock (in dollars per share)	$ 0.25		$ 0.01	$ 0.25	$ 0.01
Converted Series C Convertible Preferred Stock (in shares)	87,000,000
Affiliates of Natura&Co
Class of Stock [Line Items]
Dividends			$ 91.5
Private Placement
Class of Stock [Line Items]
Preferred stock, discount on shares		$ 8.7
Series C Preferred Stock
Class of Stock [Line Items]
Shares issued (in shares)		435,000
Shares issued		$ 435
Dividends payable				$ 91.3
Shares converted (in shares)	435,000

GOODWILL (Schedule of Goodwill)

GOODWILL (Schedule of Goodwill) (Details) $ in Millions	6 Months Ended
	Jun. 30, 2020USD ($)
Goodwill [Roll Forward]
Net balance at beginning	$ 86.2
Foreign exchange	(9.3)
Net balance at ending	76.9
Avon International
Goodwill [Roll Forward]
Net balance at beginning	20
Foreign exchange	(1)
Net balance at ending	19
Avon Latin America
Goodwill [Roll Forward]
Net balance at beginning	66.2
Foreign exchange	(8.3)
Net balance at ending	$ 57.9

FAIR VALUE FAIR VALUE ASSETS AN

FAIR VALUE FAIR VALUE ASSETS AND LIABILITIES (Details) - Fair Value, Measurements, Recurring - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Assets:
Available-for-sale securities	$ 4.2	$ 4.3
Foreign exchange forward contracts	2.7	5.6
Total Assets	6.9	9.9
Liabilities:
Foreign exchange forward contracts	10.1	3.8
Total Liabilities	10.1	3.8
Level 1
Assets:
Available-for-sale securities	4.2	4.3
Foreign exchange forward contracts	0	0
Total Assets	4.2	4.3
Liabilities:
Foreign exchange forward contracts	0	0
Total Liabilities	0	0
Level 2
Assets:
Available-for-sale securities	0	0
Foreign exchange forward contracts	2.7	5.6
Total Assets	2.7	5.6
Liabilities:
Foreign exchange forward contracts	10.1	3.8
Total Liabilities	$ 10.1	$ 3.8

FAIR VALUE (Fair Value of Finan

FAIR VALUE (Fair Value of Financial Instruments) (Details) - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Carrying Amount
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Available-for-sale securities	$ 4.2	$ 4.3
Debt maturing within one year	(28.2)	(1.8)
Long-term debt	(1,593.1)	(1,590.4)
Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Available-for-sale securities	4.2	4.3
Debt maturing within one year	(28.2)	(1.8)
Long-term debt	(1,634.3)	(1,748.1)
Foreign exchange forward contracts | Carrying Amount
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign exchange forward contracts	(7.4)	1.8
Foreign exchange forward contracts | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign exchange forward contracts	$ (7.4)	$ 1.8

DERIVATIVE INSTRUMENTS FAIR VAL

DERIVATIVE INSTRUMENTS FAIR VALUE (Details) - Fair Value, Measurements, Recurring - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Derivative [Line Items]
Foreign exchange forward contracts, asset	$ 2.7	$ 5.6
Foreign exchange forward contracts, liability	10.1	3.8
Prepaid expenses and other | Designated as Hedging Instrument
Derivative [Line Items]
Foreign exchange forward contracts, asset		0
Prepaid expenses and other | Not Designated as Hedging Instrument
Derivative [Line Items]
Foreign exchange forward contracts, asset	2.7	5.6
Accounts payable | Designated as Hedging Instrument
Derivative [Line Items]
Foreign exchange forward contracts, liability		0.6
Accounts payable | Not Designated as Hedging Instrument
Derivative [Line Items]
Foreign exchange forward contracts, liability	$ 10.1	$ 3.2

DERIVATIVE INSTRUMENTS AND HE_3

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Derivative [Line Items]
Percent of borrowings with fixed rate interest			98.00%		98.00%
Total exposure to floating rate interest rates	2.00%		2.00%
Foreign Exchange Contract
Derivative [Line Items]
Notional amount	$ 917		$ 917
Gain (loss) on foreign currency derivative instruments not designated as hedging instruments	(3.7)	$ (3.1)	6.8	$ 21.9
Foreign Exchange Contract | Cash Flow Hedging
Derivative [Line Items]
Notional amount	$ 0		$ 0

DEBT (Details)

DEBT (Details) $ in Millions	Jul. 03, 2020USD ($)	May 13, 2020USD ($)	Jan. 03, 2020USD ($)	Feb. 28, 2019USD ($)	Jun. 30, 2020USD ($)	Jun. 30, 2020ARS ($)	Dec. 31, 2019USD ($)	Jul. 31, 2019USD ($)	Feb. 28, 2019EUR (€)	Aug. 31, 2016USD ($)
Debt Instrument [Line Items]
Loan from affiliates of Natura &Co					$ 4,600,000		$ 0
Short-term financing					28,000,000
Outstanding							$ 0
Argentina Facility | Affiliates of Natura&Co
Debt Instrument [Line Items]
Loan from affiliates of Natura &Co					$ 4,600,000	$ 300
Interest rate					29.81%	29.81%
Debt term					6 months
Natura Revolving Facility Due May 2022
Debt Instrument [Line Items]
Line of credit facility		$ 100,000,000
Outstanding					$ 0
Basis spread on variable rate		7.70%
Natura Revolving Facility Due May 2022 | Subsequent Event
Debt Instrument [Line Items]
Debt term	6 months
Line of credit facility	$ 100,000,000
Outstanding	$ 40,000,000
2019 Facility
Debt Instrument [Line Items]
Debt term				3 years
Line of credit facility | €									€ 200,000,000
2015 Facility
Debt Instrument [Line Items]
Write off debt issuance costs			$ 7,800,000
2013 Notes
Debt Instrument [Line Items]
Maximum aggregate increase in interest rate related to downgrade of long-term credit ratings below investment grade					2.00%
4.6% Notes due February 2022 | 2019 Facility
Debt Instrument [Line Items]
Debt issuance costs				$ 11,000,000
5.0% Notes due March 2023
Debt Instrument [Line Items]
Interest rate					5.00%	5.00%
Principal amount					$ 461,900,000
6.95% Notes due March 2043
Debt Instrument [Line Items]
Interest rate					6.95%	6.95%
Principal amount					$ 243,800,000
7.875% Notes due August 2022
Debt Instrument [Line Items]
Interest rate										7.875%
Principal amount										$ 500,000,000
6.50% Notes due August 2022
Debt Instrument [Line Items]
Interest rate								6.50%
Principal amount								$ 400,000,000

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Income Tax Disclosure [Abstract]
Effective income tax rate, excluding discrete items			27.50%	26.00%
Income taxes provision	$ 6.1	$ 27.2	$ 14.9	$ 46.7
Effective income tax rate	(7.40%)	127.70%	(6.20%)	278.00%
Miscellaneous income tax expense	$ 2.3	$ 0.6	$ 3.8
Income tax accrual benefit				$ 2.9
Change in income tax reserve				3.3
Tax expense, uncertain tax positions				$ 0.4

MERGER WITH NATURA COSMETICOS_2

MERGER WITH NATURA COSMETICOS S.A. (Details) - USD ($) $ / shares in Units, $ in Millions	May 22, 2019	Jan. 31, 2020	Jun. 30, 2020	Jun. 30, 2020	Jun. 30, 2019	Jan. 03, 2020	Dec. 31, 2019	Dec. 30, 2019
Business Combination, Separately Recognized Transactions [Line Items]
Stock, shares authorized (in shares)							1,525,000,000
Common stock, authorized (in shares)		1,000					1,500,000,000
Common stock (in dollars per share)		$ 0.01	$ 0.01	$ 0.01			$ 0.25	$ 0.25
Preferred stock, authorized (in shares)							25,000,000
Preferred stock, par value (in dollars per share)		$ 0.01					$ 1
Stock converted or cancelled (in shares)		550,890,788
Common stock, shares outstanding (in shares)		101.34
Settlement of stock options				$ 25.8	$ 0
Minimum
Business Combination, Separately Recognized Transactions [Line Items]
Lost tax attributes		$ 480
Maximum
Business Combination, Separately Recognized Transactions [Line Items]
Lost tax attributes		550
Merger Agreement
Business Combination, Separately Recognized Transactions [Line Items]
Share conversion ratio	60.00%
Transaction costs			$ 45	$ 45			$ 44
Severance costs		24	25
Accelerated share based compensation		10	$ 10
Settlement of stock options		26
Deferred compensation expense		12
Write off debt issuance costs		$ 7.8
Merger Agreement | Affiliates of Natura&Co
Business Combination, Separately Recognized Transactions [Line Items]
Common stock composing one American depository shares (in shares)						2
American Depositary Shares | Merger Agreement
Business Combination, Separately Recognized Transactions [Line Items]
Share conversion ratio	30.00%

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - USD ($)	Jul. 03, 2020	Jun. 30, 2020	May 13, 2020	Dec. 31, 2019
Subsequent Event [Line Items]
Outstanding				$ 0
Natura Revolving Facility Due May 2022
Subsequent Event [Line Items]
Outstanding		$ 0
Line of credit facility			$ 100,000,000
Subsequent Event | Natura Revolving Facility Due May 2022
Subsequent Event [Line Items]
Outstanding	$ 40,000,000
Line of credit facility	$ 100,000,000
Debt term	6 months